<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_HDqt9YR">Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Â© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/).</p>
				</availability>
				<date type="published" when="2025-06-14">14 June 2025</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elisabetta</forename><surname>Maida</surname></persName>
							<email>elisabetta.maida@studenti.unicampania.it</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>2</label> Department of Advanced Medical and Surgical Sciences , University of Campania &quot;Luigi Vanvitelli&quot; , 80138 Naples , Italy;</note>
								<orgName type="department">Department of Advanced Medical and Surgical Sciences</orgName>
								<orgName type="institution">University of Campania &quot;Luigi Vanvitelli&quot;</orgName>
								<address>
									<postCode>80138</postCode>
									<settlement>Naples</settlement>
									<country>Italy;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paola</forename><surname>Caruso</surname></persName>
							<email>paola.caruso@unicampania.it</email>
							<idno type="ORCID">0000-0002-4756-2022</idno>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Advanced Medical and Surgical Sciences , Division of Endocrinology and Metabolic Diseases , University of Campania &quot;Luigi Vanvitelli&quot; , 80138 Naples , Italy;</note>
								<orgName type="department" key="dep1">Department of Advanced Medical and Surgical Sciences</orgName>
								<orgName type="department" key="dep2">Division of Endocrinology and Metabolic Diseases</orgName>
								<orgName type="institution">University of Campania &quot;Luigi Vanvitelli&quot;</orgName>
								<address>
									<postCode>80138</postCode>
									<settlement>Naples</settlement>
									<country>Italy;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simona</forename><surname>Bonavita</surname></persName>
							<email>simona.bonavita@unicampania.it</email>
							<idno type="ORCID">0000-0002-8561-9720</idno>
						</author>
						<author>
							<persName><forename type="first">Gianmarco</forename><surname>Abbadessa</surname></persName>
							<email>gianmarco.abbadessa@unicampania.it</email>
							<idno type="ORCID">0000-0002-8561-9720</idno>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> Department of Brain Sciences , Imperial College London , London W120BZ , UK</note>
								<orgName type="department">Department of Brain Sciences</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<postCode>W120BZ</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Giuseppina</forename><surname>Miele</surname></persName>
							<email>giuseppina.miele@unicampania.it</email>
						</author>
						<author>
							<persName><forename type="first">Miriam</forename><surname>Longo</surname></persName>
							<email>miriam.longo@unicampania.it</email>
							<idno type="ORCID">0000-0002-6459-5854</idno>
						</author>
						<author>
							<persName><forename type="first">Lorenzo</forename><surname>Scappaticcio</surname></persName>
							<email>lorenzo.scappaticcio@unicampania.it</email>
							<idno type="ORCID">0000-0002-6459-5854</idno>
						</author>
						<author>
							<persName><forename type="first">Eleonora</forename><surname>Ruocco</surname></persName>
							<email>eleonora.ruocco@unicampania.it</email>
							<idno type="ORCID">0000-0002-3500-0153</idno>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> Dermatology Unit , Department of Mental and Physical Health and Preventive Medicine , University of Campania &quot;Luigi Vanvitelli&quot; , 80138 Naples , Italy;</note>
								<orgName type="department">Department of Mental and Physical Health and Preventive Medicine</orgName>
								<orgName type="laboratory">Dermatology Unit</orgName>
								<orgName type="institution">University of Campania &quot;Luigi Vanvitelli&quot;</orgName>
								<address>
									<postCode>80138</postCode>
									<settlement>Naples</settlement>
									<country>Italy;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Francesca</forename><surname>Trojsi</surname></persName>
							<email>francesca.trojsi@unicampania.it</email>
							<idno type="ORCID">0000-0002-3790-8018</idno>
						</author>
						<author>
							<persName><forename type="first">Katherine</forename><surname>Esposito</surname></persName>
							<email>katherine.esposito@unicampania.it</email>
							<idno type="ORCID">0000-0002-3790-8018</idno>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Advanced Medical and Surgical Sciences , Division of Endocrinology and Metabolic Diseases , University of Campania &quot;Luigi Vanvitelli&quot; , 80138 Naples , Italy;</note>
								<orgName type="department" key="dep1">Department of Advanced Medical and Surgical Sciences</orgName>
								<orgName type="department" key="dep2">Division of Endocrinology and Metabolic Diseases</orgName>
								<orgName type="institution">University of Campania &quot;Luigi Vanvitelli&quot;</orgName>
								<address>
									<postCode>80138</postCode>
									<settlement>Naples</settlement>
									<country>Italy;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Luigi</forename><surname>Lavorgna</surname></persName>
							<email>luigi.lavorgna@policliniconapoli.it</email>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><forename type="middle">Ida</forename><surname>Maiorino</surname></persName>
							<email>mariaida.maiorino@unicampania.it</email>
							<idno type="ORCID">0000-0003-4659-7546</idno>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Advanced Medical and Surgical Sciences , Division of Endocrinology and Metabolic Diseases , University of Campania &quot;Luigi Vanvitelli&quot; , 80138 Naples , Italy;</note>
								<orgName type="department" key="dep1">Department of Advanced Medical and Surgical Sciences</orgName>
								<orgName type="department" key="dep2">Division of Endocrinology and Metabolic Diseases</orgName>
								<orgName type="institution">University of Campania &quot;Luigi Vanvitelli&quot;</orgName>
								<address>
									<postCode>80138</postCode>
									<settlement>Naples</settlement>
									<country>Italy;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Pediatric Neurology , Santobono-Pausilipon Childrens Hospital , 80129 Naples , Italy</note>
								<orgName type="department">Pediatric Neurology</orgName>
								<orgName type="institution">Santobono-Pausilipon Childrens Hospital</orgName>
								<address>
									<postCode>80129</postCode>
									<settlement>Naples</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_9hnNPXj">Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2025-06-14">14 June 2025</date>
						</imprint>
					</monogr>
					<idno type="MD5">DF5997BB8C80D5E145FF055FAFCA3BE5</idno>
					<idno type="DOI">10.3390/jcm14124240</idno>
					<note type="submission">Received: 28 April 2025 Revised: 5 June 2025 Accepted: 11 June 2025</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T12:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_m2NBJ4z">diabetes</term>
					<term xml:id="_KEN5EyY">digital health</term>
					<term xml:id="_g4TUnU2">neurological complications</term>
					<term xml:id="_CZ4b4vM">technology</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_SwT7gAM"><p xml:id="_j5DVKu4"><s xml:id="_f6tKafr">Background/Objectives: Despite the recent advances in glucose-lowering therapy, achieving diabetes control remains challenging.</s><s xml:id="_eYCyrkK">With the advancing progress of innovative digital health technologies, management of diabetes is taking advantage from telehealth and telemedicine, which allow for remote assistance, virtual visits, and monitoring of diabetes-related parameters, and facilitate the exchange of documents and reports to support clinical decisions.</s><s xml:id="_gB9t973">We aim to provide an overview of the impact of telehealth and digital technologies on the care of people with diabetes, from therapeutic management to the assessment of complications.</s><s xml:id="_8RTyyrN">Methods: A comprehensive literature search was conducted using PubMed to assess the impact of digital technologies and telemedicine on diabetes care.</s><s xml:id="_j2pZYnn">Results: From the comprehensive PubMed search, 86 peer-reviewed studies were selected based on relevance, clinical significance, and methodological quality.</s><s xml:id="_7JGSECd">The selected literature addressed digital health tools such as continuous glucose monitoring, connected insulin pens, automatic insulin delivery systems, mobile applications, and telemedicine systems.</s><s xml:id="_pYQtG2s">These interventions were associated with improved glycemic control (e.g., reduced HbA1c, increased time in range), better adherence to therapy, enhanced patient engagement, and more efficient management of complications such as neuropathy, retinopathy, and cardiovascular risk.</s><s xml:id="_aUDjwGB">Conclusions: Telehealth may offer a fully patientcentered approach to disease management through a tailored individual management plan.</s><s xml:id="_ssRxTGj">This may lead to an improvement in adherence to proper therapy and lifestyle, resulting in a subsequent increase in the quality of life.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="19" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1." xml:id="_k2ef8hc">Introduction</head><p xml:id="_BpYnPbe"><s xml:id="_uzvT6BS">Together with cardiovascular diseases, cancer, and respiratory chronic diseases, diabetes mellitus (DM) is included in the category of "non communicable chronic diseases" (NCDs).</s><s xml:id="_YarBBgj">NCDs are responsible for the highest burden of morbidity and mortality worldwide, and these four groups of diseases account for over 80% of all NCD-related premature deaths <ref type="bibr">[1]</ref>.</s><s xml:id="_vxHQ3WK">With a worldwide prevalence on the rise, type 1 diabetes (T1DM) and type 2 diabetes (T2DM) represent significant global health threats <ref type="bibr" target="#b0">[2]</ref>.</s><s xml:id="_nfkuAAs">Projections show that by 2045, one in eight adults (approximately 783 million) will be living with DM, indicating a 46% increase in its prevalence rate.</s><s xml:id="_S8Kme4U">This scenario implies an ever-growing number of people requiring lifelong care and clinical assistance, with an increasing burden on National Healthcare Systems.</s></p><p xml:id="_6BmmUAJ"><s xml:id="_N9snttA">As a "pervasive" disease, diabetes requires continuous monitoring, frequent followups and multidisciplinary management to optimize the achievement of therapeutic targets within a holistic person-centered approach <ref type="bibr" target="#b1">[3]</ref>.</s><s xml:id="_uXztQbv">Additionally, the management of DM has to address not only glucose-lowering therapy but also the control of the other cardiovascular risk factors and related comorbidities <ref type="bibr" target="#b1">[3]</ref>.</s></p><p xml:id="_m2rFmdq"><s xml:id="_ywbyfWb">Despite the recent advances in glucose-lowering therapy, achieving diabetes control remains challenging.</s><s xml:id="_d5ETJDW">Key contributors to therapeutic failure include poor patients' adherence to medications and clinical inertia, which is the reluctance of clinicians to initiate or intensify therapy according to evidence-based guidelines <ref type="bibr" target="#b2">[4]</ref>.</s><s xml:id="_4u5uMH7">To overcome the multiple and challenging obstacles to the optimal diabetes control, an organized and structured model of chronic care should be proposed for people with diabetes (PwD) <ref type="bibr" target="#b3">[5]</ref>.</s><s xml:id="_3YNNCN2">With the increasing progress of innovative digital health technologies, the development of a "digital virtual diabetes clinic" has provided a valuable opportunity to implement effective and efficient diabetes management (Figure <ref type="figure" target="#fig_0">1</ref>) <ref type="bibr" target="#b4">[6]</ref>.</s><s xml:id="_tdNZsjb">The figure illustrates the conceptual framework of a digital, virtual diabetes clinic, highlighting the integration of innovative digital health technologies for effective and efficient diabetes management.</s><s xml:id="_3UgTXJG">Through at-home blood glucose monitoring, telemedicine consultations, and personalized digital interventions, the digital virtual clinic offers a comprehensive approach to diabetes management, enhancing patient engagement and clinical outcomes.</s></p><p xml:id="_JSRjbcY"><s xml:id="_WQ7E8ZB">The aim of this narrative review was to evaluate the impact of telehealth and digital technologies on the care of PwD, from therapeutic management to the assessment of complications.</s><s xml:id="_nMMvrjE">The goal was to provide a comprehensive understanding of how telehealth can revolutionize diabetes care, enhance patient care, and contribute to the efficiency of national healthcare systems.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2." xml:id="_aDFbMSx">Materials and Methods</head><p xml:id="_2JKMD3s"><s xml:id="_djKBMQR">This narrative review aimed to explore the role of telemedicine and digital health technologies in the management of diabetes, with a particular focus on their application in addressing both systemic and neurological complications.</s><s xml:id="_vwaKrcC">To this end, a comprehensive literature search was conducted in PubMed, targeting publications from January 2015 to December 2024; however, no lower time limit was strictly applied, and earlier studies were included if deemed conceptually or clinically relevant.</s></p><p xml:id="_KmtTjUq"><s xml:id="_ZbKK8GA">The search strategy included combinations of the following terms and keywords: "diabetes", "type 1 diabetes", "type 2 diabetes", "diabetes care", "diabetes complications", "diabetes risk factors", "digital health", "digital therapeutics", "telemedicine", "telehealth", "televisits", "mobile applications", "web-based interventions", "continuous glucose monitoring", "connected insulin pens", "automatic insulin delivery", "unmet needs", "treatment gaps", "patient needs".</s></p><p xml:id="_KjFmtUQ"><s xml:id="_RVVehCc">Inclusion criteria were as follows:</s></p><p xml:id="_uAG9fvt"><s xml:id="_sAnNJ2h">1. Peer-reviewed articles published in English; 2. Studies addressing the use of digital health tools in diabetes care, including type 1 diabetes, type 2 diabetes, and gestational diabetes; 3. Articles focusing on therapeutic strategies, monitoring technologies, and the management or prevention of complications.</s></p><p xml:id="_BcvfdP9"><s xml:id="_Mwn8WHr">We prioritized peer-reviewed studies reporting clinical outcomes in people with diabetes, including reviews, meta-analyses, randomized controlled trials, and observational studies, if relevant to the scope.</s><s xml:id="_QKck8xv">Non-English publications, editorials, and opinion pieces were excluded.</s><s xml:id="_hfDy6Hy">Relevant articles were identified and located to examine citing and cited-by articles.</s><s xml:id="_jJ3dSje">In total, 86 articles were selected for inclusion based on their thematic relevance and scientific contribution.</s><s xml:id="_dcjDgNR">The review followed the Scale for the Assessment of Narrative Review Articles (SANRA) criteria.</s></p><p xml:id="_5je5jzr"><s xml:id="_FsUmFCY">A narrative synthesis was developed to describe the various digital health technologies and to assess their role in symptom management, therapeutic intervention, and complication prevention in diabetes care.</s><s xml:id="_7RMqGKh">An overview of the principal digital health interventions, their key proximal outcomes, and the long-term complications they target is provided in Table <ref type="table">S1</ref> of Supplementary Materials.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3." xml:id="_EfdCBHR">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1." xml:id="_ujyfyBN">Unmet Needs in PwD</head><p xml:id="_wbuPtwf"><s xml:id="_6tQ5pgE">Several studies have attempted to investigate the unmet needs of people with both T1DM and T2DM <ref type="bibr" target="#b5">[7]</ref><ref type="bibr" target="#b6">[8]</ref><ref type="bibr" target="#b7">[9]</ref>, defined as the range of difficulties and challenges experienced by individuals throughout the course of the disease, from diagnosis to long-term therapeutic, clinical, and psychosocial management.</s></p><p xml:id="_cUWgCjr"><s xml:id="_Z9a5bbC">The DAWN2 study <ref type="bibr" target="#b6">[8]</ref>, which took its name from its predecessor, the DAWN study <ref type="bibr" target="#b5">[7]</ref>, was conducted in 17 states on more than 16,000 individuals, including patients with both T1DM and T2DM, caregivers, family members, and healthcare professionals.</s><s xml:id="_nsgqwvT">An online questionnaire was administered, covering several topics, such as the impact of the disease on their quality of life, diabetes management and control, support from family members, society and healthcare system, and unmet needs and hopes for the future.</s><s xml:id="_SmBCK9V">The results showed a clear need for psychosocial support, with 44.6% reporting distress related to the diagnosis and 13.8% showing signs of potential depression.</s><s xml:id="_7n2kcHW">The majority of PwD reported to be poorly involved by their physician and emphasized the need to be provided with a better education on self-management as well as psychological and social support.</s><s xml:id="_pjB9qAx">The issue of support was also raised by family members and caregivers who perceived diabetes as a physical and emotional burden (35.3%), with a struggle to find the appropriate way to help their loved ones.</s></p><p xml:id="_6JGvr6Q"><s xml:id="_53vm2cP">Raposo and colleagues <ref type="bibr" target="#b7">[9]</ref> administered an online questionnaire to 300 individuals newly diagnosed with T2DM and currently treated with glucose-lowering drugs.</s><s xml:id="_ruFU2sM">The responses revealed a low-to-medium level of knowledge of diabetes and related conditions prior to diagnosis (mean: 4.4 on a scale of 0 to 10); after the first visit, most responders were very satisfied with the information received.</s><s xml:id="_hdudSAs">The most important unmet needs that emerged were the need to improve both the awareness and information about T2DM to enable early diagnosis; the desire for better support concerning diet and dietary habits; and lastly, the expectation for a new method of blood glucose monitoring that could be real-time and painless.</s></p><p xml:id="_Adeh7Kg"><s xml:id="_AtPHrGg">In the light of these considerations, it became essential to highlight possible solutions and assess the corresponding patient satisfaction.</s><s xml:id="_wWMwJVP">Digital health applied to the complexities of chronic conditions has the enormous potential to improve clinical care, thus leading to a decrease in the rate of acute and chronic complications and to an improvement of the quality of life, relieving the economic and social burden on the healthcare system and caregivers <ref type="bibr" target="#b8">[10]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2." xml:id="_Hyuyatb">Telehealth and Its Application in Diabetes Care</head><p xml:id="_whAyJu2"><s xml:id="_MmDtXP6">Telehealth is defined as the utilization of digital technologies to deliver medical care, health education, and public health services by connecting multiple users in separate locations <ref type="bibr" target="#b9">[11]</ref>, indicating a model of care delivery rather than a specific treatment or therapeutic strategy.</s><s xml:id="_4azfVkB">As a subset of telehealth, telemedicine refers to the exchange of medical information from one site to another via electronic communications to improve a patient's clinical health status <ref type="bibr" target="#b9">[11]</ref> (Table <ref type="table">1</ref>).</s><s xml:id="_zQynTAn">As a chronic disease requiring frequent interaction between patients and healthcare providers (HCPs), diabetes could benefit from a remote approach based on digital technologies.</s></p><p xml:id="_8QNeP3f"><s xml:id="_hSFXaaR">Numerous guidelines or international panels have identified three key areas of application for telemedicine in diabetes care to improve patients' outcomes, increase access to care and reduce costs: 1. secondary prevention; 2. diagnosis; and 3. treatment <ref type="bibr" target="#b4">[6,</ref><ref type="bibr" target="#b10">12]</ref>.</s><s xml:id="_sq3svxZ">In general, telemedicine allows for remote assistance and virtual visits monitoring diabetesrelated parameters and facilitates communications between HCPs for consultations and the exchange of documents and reports to support clinical decisions.</s><s xml:id="_aSqq23d">For these purposes, various technologies can be employed to support telehealth delivery of programs and services, including digital technologies such as continuous glucose monitoring (CGM) and automatic insulin delivery (AID), smartphone apps for mobile phones, websites or cloud-upload technologies for data download and remote monitoring algorithms, along with combinations of multiple technologies.</s></p><p xml:id="_p8TYpsg"><s xml:id="_rhr42Kv">In a recent systematic review, Eberle and colleagues <ref type="bibr" target="#b11">[13]</ref> addressed the role of telemedicine for T1DM and T2DM management, categorizing the available intervention protocols into four groups: real-time audio intervention, real-time video intervention, asynchronous intervention, and lastly, combined intervention.</s><s xml:id="_wyg2DrQ">The results showed an equivalence of these approaches for the remote management of diabetic patients; however, it is imperative to adapt each of them to the specific needs of each patient <ref type="bibr" target="#b12">[14]</ref>.</s></p><p xml:id="_f3V8NBq"><s xml:id="_6pRb2tZ">A recent meta-analysis conducted by Tchero and colleagues <ref type="bibr" target="#b13">[15]</ref> reviewed 42 randomized controlled trials (RCTs) with the aim of comparing clinical effectiveness of telemedicine in the management of diabetes with the traditional approach.</s><s xml:id="_jeBEAzm">The results showed that telemedicine could be more effective than traditional practice.</s><s xml:id="_z8QXfTy">In particular, telemedicine interventions lasting longer than 6 months tended to provide better results than those of shorter durations.</s><s xml:id="_H2zZBuJ">Moreover, telemedicine programs have proved to be more successful in older people and T2DM, as these subjects may undergo cognitive and memory decline.</s><s xml:id="_awuj3x9">Although this finding may seem a contradiction, it may be explained by the observation that in patients with mild cognitive impairment, telemedicine can compensate for possible forgetfulness in diabetes management.</s><s xml:id="_Z9fzzdV">On the other hand, in patients with a more advanced cognitive deterioration, remote telemanagement can help caregivers in their difficult task of daily organization.</s></p><p xml:id="_C5YT4mU"><s xml:id="_xAyDj2T">Table <ref type="table">1</ref>.</s><s xml:id="_nKnMrMy">Definitions and components of telehealth in diabetes management.</s><s xml:id="_PBhxk6n">The table provides definitions of components of telehealth in diabetes management.</s><s xml:id="_XcczBk4">Telehealth, defined as the utilization of digital technologies to deliver medical care and healthcare services remotely, includes different modalities such as televisit, teleconsultation, tele-education, and telemonitoring.</s><s xml:id="_Na5gbXG">Each modality performs distinct functions in the delivery of remote healthcare, contributing to improved patient care and outcomes in diabetes management.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VjEN2BX">TELEHEALTH TELEMEDICINE IN DIABETES MANAGEMENT</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4vwj34b">Televisit</head><p xml:id="_5UHr68W"><s xml:id="_Z8zh633">Televisit is a healthcare act in which the doctor interacts remotely with the patient, with the prescription of drugs or treatments during the televisit.</s><s xml:id="_JF6tEj4">The visit must take place in real or deferred time.</s><s xml:id="_UerW4Bn">A healthcare professional who is close to the patient can assist the doctor.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_meuDqUF">Teleconsultation</head><p xml:id="_EFmcYdy"><s xml:id="_wA2E4bR">Teleconsultation represents a remote consultancy activity between doctors that allows a doctor to ask the advice of one or more doctors on the indication of diagnosis and/or choice of therapy without the physical presence of the patient, on the basis of medical information related to patient care.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TjynDf8">Tele-education</head><p xml:id="_NKBpcvU"><s xml:id="_w8BSPyv">Tele-education refers to any educational or learning process in which the learner is geographically apart from the instructor and/or the educational resources.</s></p><p xml:id="_ck4jewz"><s xml:id="_J5ezkMP">Tele-education can be synchronized and not-synchronized and is commonly associated with in-person lessons or professional training procedures.</s></p><p xml:id="_MP8pKsx"><s xml:id="_WJGKa7J">Telemonitoring Telemonitoring corresponds to the transmission and/or the sharing of clinical data to a healthcare provider through electronic and web-based systems.</s><s xml:id="_CQTfKTD">Telemonitoring can include both non-reactive data collection and delayed and/or continuous analytic and decision-making functions.</s></p><p xml:id="_ZXYw9kK"><s xml:id="_h2fDtcZ">Finally, a recent review <ref type="bibr" target="#b14">[16]</ref> sought to shed light on the cost-benefit of telemedicine for diabetes to facilitate its widespread adoption.</s><s xml:id="_NMcX7Aa">Telemonitoring interventions together with teleophthalmology interventions for the assessment of microvascular complications in the retina were evaluated.</s><s xml:id="_wFhHsGf">The most important result in terms of cost savings was in teleophthalmology, which was found to be promising for early detection of microvascular ocular complications.</s><s xml:id="_VCPF2Ag">A similar significant result was not observed for telemonitoring tools; however, several studies <ref type="bibr" target="#b15">[17,</ref><ref type="bibr" target="#b16">18]</ref> showed the need to implement telemedicine techniques especially for rural populations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.1." xml:id="_ny6EH97">Continuous Glucose Monitoring</head><p xml:id="_fYBRfSE"><s xml:id="_V66Bh9A">Glucose monitoring plays a key role in both the treatment and management of insulintreated PwD <ref type="bibr" target="#b17">[19,</ref><ref type="bibr" target="#b18">20]</ref>.</s><s xml:id="_qdqFB9n">A CGM system measures blood glucose levels on a near-continuous basis, providing information of blood glucose response to insulin dosing, meals, exercise, daily activities and other factors.</s><s xml:id="_Nekg3cS">This information enables HCPs to make necessary adjustments to the therapy as needed.</s><s xml:id="_GpBnHAb">Currently, two types of CGM devices are available: 1. real-time CGM (rtCGM), which continuously assesses glucose levels and are equipped with automated alarms to alerts at specific glucose thresholds and 2. intermittently scanned CGM (isCGM), which displays glucose values when swiped by a reader or a smart phone, revealing the current glucose levels.</s><s xml:id="_s53gUuN">Finally, the so called "blinded" CGM measures glucose levels that are not immediately shown to the user but retrospectively analyzed by both patients and physicians to evaluate glycemic patterns and trends.</s></p><p xml:id="_CYZGTrP"><s xml:id="_SF7n7We">Data derived from CGM can be summarized and analyzed with software that generates reports (glucose indices, trends and statistics related to sensor usage, the time spent in the range of normoglycemia, hypoglycemia or hyperglycemia).</s><s xml:id="_TA9g9Ze">Numerous international consensus statements recommend the Ambulatory Glucose Profile as the default report to summarize CGM data over multiple days of wear <ref type="bibr" target="#b19">[21]</ref>.</s></p><p xml:id="_2aHxVxV"><s xml:id="_Db6dq55">In numerous RCTs, rtCGM has demonstrated an improvement of glucose control in terms of reduction in HbA1c, increase in time in range (TIR) and a decrease in the time spent in hypoglycemia and hyperglycemia.</s><s xml:id="_htP4FQJ">The benefits were more significant in PwD who employed the sensor for an extended period <ref type="bibr">[22]</ref><ref type="bibr" target="#b21">[23]</ref><ref type="bibr" target="#b22">[24]</ref><ref type="bibr" target="#b23">[25]</ref><ref type="bibr" target="#b24">[26]</ref><ref type="bibr" target="#b25">[27]</ref><ref type="bibr" target="#b26">[28]</ref><ref type="bibr" target="#b27">[29]</ref><ref type="bibr" target="#b28">[30]</ref><ref type="bibr" target="#b29">[31]</ref>.</s><s xml:id="_nd7e5xq">Most of the studies were conducted on adults and youth with T1DM treated with continuous subcutaneous insulin infusion (CSII) or multiple daily injections of insulin (MDI).</s><s xml:id="_qE7zNSA">The results showed substantial benefits associated with the use of rtCGM in adults of all ages, as long as participants in the studies continued to use the device <ref type="bibr" target="#b30">[32]</ref>.</s><s xml:id="_DcJtp3G">Few studies have evaluated the effect of rtCGM compared with usual care in people with T2DM <ref type="bibr" target="#b25">[27,</ref><ref type="bibr" target="#b31">33]</ref> or in pregnant women with T1DM on intensive insulin regimen <ref type="bibr" target="#b32">[34]</ref>, with encouraging results.</s></p><p xml:id="_ZNPV2Mh"><s xml:id="_yXyxhKx">Studies focusing on isCGM are more limited.</s><s xml:id="_5w9KCxJ">However, there is evidence that isCGM with optional alarms is associated with a reduction in HbA1c in people with T1DM <ref type="bibr" target="#b33">[35]</ref> and a decreased rate of hypoglycemia in T2DM <ref type="bibr" target="#b34">[36,</ref><ref type="bibr" target="#b35">37]</ref>.</s><s xml:id="_QKKqCXA">Emerging evidence associates the use of isCGM with the reduction in diabetes-related events and all-cause hospitalizations in PwD following therapies with less intensive insulin regimen or glucose-lowering oral drugs <ref type="bibr" target="#b36">[38,</ref><ref type="bibr" target="#b37">39]</ref>.</s><s xml:id="_BHjPWBF">Moreover, a meta-analysis of RCTs reported that, in T1DM and T2DM, both rtCGM and isCGM are associated with a modest reduction in HbA1c (-0.2%) with an overall increase in TIR of 70 min and fewer episodes of hypoglycemia and hyperglycemia <ref type="bibr" target="#b38">[40]</ref>.</s></p><p xml:id="_SYYypNW"><s xml:id="_NNjWwqR">Finally, T1DM, T2DM, pregnancy during intensive insulin therapy, monitoring during regular physical exercise, new onset of diabetes, and frailty have been recognized as the clinical scenarios best fitting the need for using rtCGM or isCGM, regardless of baseline HbA1c or individualized HbA1c target <ref type="bibr" target="#b39">[41]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.2." xml:id="_XWMjrP7">Connected Insulin Pens</head><p xml:id="_ngEUmF4"><s xml:id="_ZrhpeJF">"Connected" insulin pens are devices capable of automatically transmitting data via Bluetooth to management apps on smartphones, representing a new valuable frontier for MDI therapy.</s><s xml:id="_xyGhUjT">These pens include tracking insulin pens (TIPs) and smart insulin pens (SIPs).</s><s xml:id="_CWRsU6f">TIPs record the last dose of insulin administered by the device and offer reminders for insulin doses through cloud connectivity.</s><s xml:id="_yJbuBy6">SIPs integrate data such as glucose and carbohydrates from other technological devices or apps, elaborate reports that can be shared with HCPs and provide clinical decision support through an automated insulin dose calculator based on individualized insulin therapy settings.</s></p><p xml:id="_SqtPsCa"><s xml:id="_B7rEUNH">Emerging evidence suggests that the use of connected insulin pens is associated with increased TIR and fewer missed boluses in T1DM treated with a basal-bolus insulin regimen <ref type="bibr" target="#b40">[42]</ref>, indicating a beneficial impact on glucose control and dosing behavior <ref type="bibr" target="#b41">[43]</ref>.</s></p><p xml:id="_WuhMAAn"><s xml:id="_K3XUuN3">In a cost-effectiveness analysis, the use of SIPs was associated with a per-patient improvement of 0.90 years in mean life expectancy and an increased 1.15 quality-adjusted life-years, along with mean cost savings over standard care <ref type="bibr" target="#b42">[44]</ref>.</s><s xml:id="_SmgzDvu">These results were mainly driven by a lower frequency and delayed onset of complications.</s><s xml:id="_WhVf6sh">Moreover, the lower number of severe hypoglycemia events observed when these devices are used in combination with CGM may further contribute to the potential beneficial economic impact of SIPs <ref type="bibr" target="#b43">[45]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.3." xml:id="_sMES9Vp">Automatic Insulin Delivery</head><p xml:id="_gpQqKmF"><s xml:id="_fF6SGcJ">AID systems include technologies that integrate data from CGM, insulin pumps and control algorithms to automatically regulate subcutaneous insulin delivery.</s><s xml:id="_rqHCCwK">The earlier AID system included insulin pumps with automated suspension of insulin delivery at low glucose levels (low glucose suspend, LGS) or for predictive hypoglycemia (predictive low glucose suspend, PLGS).</s><s xml:id="_twHTV4R">These technologies initially enabled the glucose-responsive regulation of insulin delivery to address hypoglycemia <ref type="bibr" target="#b44">[46,</ref><ref type="bibr" target="#b45">47]</ref>.</s></p><p xml:id="_5Kdg3ZU"><s xml:id="_NgcFEU6">The most recent closed-loop technology currently available is the advanced hybrid closed-loop system, which automatically and continually modulate basal insulin delivery in response to sensor glucose levels.</s><s xml:id="_4wjdNNM">It can also deliver automatic correction boluses in case of glycemic spikes but still requires the manual entry of carbohydrates consumed to calculate prandial doses.</s><s xml:id="_BTwm5Xy">The "full" AID will automatically adjust all the required insulin, including prandial insulin at meals.</s></p><p xml:id="_NNe9dYW"><s xml:id="_nVetnXY">Studies focusing on various AID systems with different algorithms, pumps, and sensors have been conducted in both adults and children with diabetes <ref type="bibr" target="#b46">[48]</ref><ref type="bibr">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref>.</s><s xml:id="_dFs6MCE">Meta-analysis of RCTs provides evidence that AID systems may improve TIR, reduce hyperglycemia and hypoglycemia and modestly decrease HbA1c levels, compared with control therapy (conventional pump therapy or sensor-augmented pump therapy) <ref type="bibr" target="#b51">[52,</ref><ref type="bibr" target="#b52">53]</ref>.</s><s xml:id="_kPwCZ6Y">PwD preference and the selection of individuals (and caregivers) capable of safely and effectively using the devices are relevant aspects for a valuable and effective therapy with AIDs <ref type="bibr" target="#b18">[20,</ref><ref type="bibr" target="#b53">54]</ref>.</s><s xml:id="_fpDKj2a">This scenario is currently expanding with the advent of "Do-it-yourself" AID systems, which use commercially available CGM systems and insulin pumps combined with an open-source algorithm <ref type="bibr" target="#b53">[54]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.4." xml:id="_MT9dYFG">Digital Health Apps</head><p xml:id="_XXkCjUK"><s xml:id="_qugJkwR">The recent and rapid progress in the field of diabetes technologies has led to the development of numerous mobile apps intended to increase the self-management abilities of PwD, facilitate communication between PwD and HCPs and improve compliance with tailored treatment.</s><s xml:id="_rTFvseC">These Apps may help PwD improve health outcomes by supporting healthy behaviors, promoting glucose monitoring, assisting with result interpretation, guiding medication change, providing alerts for blood glucose variation, and ultimately, reducing complications.</s></p><p xml:id="_b5mnPz3"><s xml:id="_cCAZ3Ht">The most commonly used digital health apps in diabetes care can be divided into three categories: 1. Apps used for tracking health and wellness, 2. apps acting as standalone medical devices, and 3. apps that display, download, share and/or use data from devices involved in self-blood glucose monitoring, CGM, insulin pumps or integrated system of insulin delivery and CGM, such as AID or artificial pancreas.</s></p><p xml:id="_yjczZCz"><s xml:id="_QxjdBKA">Apps used for tracking wellness include both nutrition and physical activity apps.</s><s xml:id="_V3yQ7yw">These tools enable users to check the energy content of food, serve as nutrition tracker or food diary, support in planning meals and insulin dosing <ref type="bibr" target="#b54">[55]</ref>, monitor daily physical activity, count calories and set goals for exercise and weight management <ref type="bibr" target="#b55">[56]</ref>.</s></p><p xml:id="_KHNnyZn"><s xml:id="_3f5jDAJ">Glucose monitoring apps offer the possibility to aggregate data often derived from an external device (i.e., a glucometer or a CGM) and build graphs to show glucose trends.</s><s xml:id="_uP97dqT">These apps are frequently integrated with a "bolus calculator", which allows PwD to establish the insulin dose in response to the carbohydrate content of each meal, the basal insulin dose or correction doses needed in case of sudden glucose spikes.</s><s xml:id="_y6gNayS">Apps supporting insulin delivery are connected to pens or insulin pumps to collect and display data, suggest boluses, download insulin and glucose data, providing a comprehensive overview for decision assistance.</s><s xml:id="_CfJnR6Z">Finally, AID systems consist of a CGM, an insulin pump and an algorithm that adjust the basal insulin rate or provide automatic correction boluses (advanced closed loop) based on glucose levels captured by the sensor on patients <ref type="bibr" target="#b53">[54]</ref>.</s></p><p xml:id="_yaccjTG"><s xml:id="_WyfgKc3">Several clinical trials focusing on interventions based on apps to manage diabetes have been conducted in various population, including in children and adolescents with T1DM <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b57">58]</ref>, adults with both T1DM and T2DM <ref type="bibr" target="#b58">[59]</ref><ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref> and women with pregnancy diabetes <ref type="bibr" target="#b62">[63]</ref>.</s></p><p xml:id="_9w6dUNZ"><s xml:id="_utQYsKE">Most studies identified the reduction in HbA1c as the primary outcome associated with the use of apps, compared with control strategies <ref type="bibr" target="#b58">[59]</ref><ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b63">64]</ref>.</s><s xml:id="_RKdUz5U">In many cases, the improvement of glycemic outcomes was enhanced with healthcare professional feedback <ref type="bibr" target="#b59">[60,</ref><ref type="bibr" target="#b61">62,</ref><ref type="bibr" target="#b63">64]</ref> highlighting the importance of creating connections and sharing data between PwD and HCPs for an effective care process.</s><s xml:id="_GFf5fQR">The main limitation of these studies were the short duration of the intervention and the relatively small number of participants.</s><s xml:id="_AhRnjYf">Moreover, there is evidence suggesting that mobile app intervention may have beneficial impacts on medication adherence and glycemic parameters in people with T2DM <ref type="bibr" target="#b64">[65]</ref>.</s></p><p xml:id="_8MFfEkK"><s xml:id="_DJ5wG29">However, since mobile apps designed for health and wellness are largely unregulated, there is need for regulation, standardization, and quality control, to promote a safe and effective approach, increase patient engagement, and improve disease outcomes <ref type="bibr" target="#b65">[66]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.5." xml:id="_XuzCDK8">Websites and Cloud-Upload Technologies</head><p xml:id="_8MxUcJG"><s xml:id="_6jYzTWx">Websites and cloud-upload technologies represent a relatively recent opportunity for managing diabetes remotely.</s><s xml:id="_mR4jK4k">This is further emphasized by the growing adoption of blood glucose monitoring systems (self-blood glucose monitoring (SBGM), isCGM, rtCGM) in clinical practice.</s><s xml:id="_rmF5j4f">These systems have significantly contributed to diabetes management, regardless of the type of glucose-lowering treatment, whether MDI or CSII <ref type="bibr" target="#b38">[40,</ref><ref type="bibr" target="#b39">41]</ref>.</s></p><p xml:id="_VjqVhM6"><s xml:id="_ZQtAd6t">Glucose monitoring data can be collected over time and sent to the cloud to review summary statistics and recognize trends of glucose levels.</s><s xml:id="_4WV5Nx5">Downloading these data may help HCPs provide individualized recommendations for therapy, evaluate the efficacy of glucose-lowering therapy and educate patients on interventions that can improve their clinical status.</s><s xml:id="_ycFqhAt">In addition, remote monitoring represents a valuable strategy to intervene promptly with appropriate and immediate feedback providing treatment modification if needed.</s></p><p xml:id="_jxQR6ur"><s xml:id="_snAuyaM">Tools for downloading data include software and web-based platforms that are accessible by both PwD or HCPs.</s><s xml:id="_Y39ZtvV">Data are typically summarized in tables, charts or graphs that report patterns and trends in blood glucose levels.</s><s xml:id="_NJtmu7d">Additionally, information on meals, insulin doses, and physical activity can also be visualized.</s><s xml:id="_mc6FuvX">PwD may link their personal accounts to HCP's professional account for data sharing and remotely reviewing the information.</s></p><p xml:id="_V79zRBq"><s xml:id="_4NdNdn3">Downloading and reviewing glucose data through web-based platforms have been associated with a significant reduction in HbA1c in RCTs <ref type="bibr" target="#b66">[67]</ref><ref type="bibr" target="#b67">[68]</ref><ref type="bibr" target="#b68">[69]</ref>.</s><s xml:id="_vh9My6K">Evidence from clinical trials also suggests that telemonitoring in people with T2DM leads to improvement in diabetes control <ref type="bibr" target="#b69">[70]</ref><ref type="bibr" target="#b70">[71]</ref><ref type="bibr" target="#b71">[72]</ref>, comorbidities <ref type="bibr" target="#b70">[71,</ref><ref type="bibr" target="#b72">73]</ref> and a better quality of life <ref type="bibr" target="#b72">[73,</ref><ref type="bibr" target="#b73">74]</ref>.</s><s xml:id="_3beqZEe">Moreover, a recent meta-analysis of 30 RCTs, including 4678 PwD, reported that system practicality, user engagement, patient characteristics and disease education are the main factors influencing the effect of telemonitoring on glucose control <ref type="bibr" target="#b69">[70]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.6." xml:id="_GMfmyv3">Televisits</head><p xml:id="_nYtddMW"><s xml:id="_cn2VVHM">A higher frequency of visits has been associated by Kaufman and colleagues with a better control of HbA1c <ref type="bibr" target="#b74">[75]</ref>.</s><s xml:id="_M4BDyzr">Indeed, results of their 3-year study showed a significantly lower HbA1C value for patients with 3-4 visits per year, compared to those with only 1 or 2 visits.</s><s xml:id="_tc8QeKC">On this basis, it should be mandatory to improve patients' adherence to follow-up.</s><s xml:id="_g9Sh4qA">For patients skipping appointments for reasons like work, school or distance from DM centers, telemedicine could be a suitable tool to overcome such obstacles.</s></p><p xml:id="_4DSQfQk"><s xml:id="_rW9YBaR">The promising results of telemedicine for diabetes management were already investigated prior to the COVID-19 pandemic.</s><s xml:id="_s32ZamV">Kassar et al. <ref type="bibr" target="#b75">[76]</ref> conducted a study on 106 inmates with diabetes who agreed to remote visits with experienced endocrinologists, amounting to a total of 264 televisits.</s><s xml:id="_KGjcWQ2">At the end of the follow-up, there was an improvement in HbA1c levels in more than half of the patients, as well as better control of cardiovascular risk factors such as hypertension and hyperlipidemia.</s><s xml:id="_PXQVVVM">A pre-pandemic study conducted by Tonyushkina and colleagues <ref type="bibr" target="#b76">[77]</ref> recruited 10 young patients with DMT1 to attend remote monitoring visits.</s><s xml:id="_5SqvtJ8">At the end of each televisit, which took 25 to 45 min, the diabetologist informed the patients about any therapeutic and lifestyle adjustments.</s><s xml:id="_fEmvfYE">Although no significant changes in HbA1c values were recorded, all patients were very satisfied with the telemedicine visits and wanted to continue clinical follow-up with the same modality.</s></p><p xml:id="_MJNyyuY"><s xml:id="_BjGWdZJ">The COVID-19 pandemic made it impossible for many patients with chronic diseases to attend their regular check-ups at their referral centers.</s><s xml:id="_HhRZcAb">As a result, the number of remote visits increased considerably, leading consequentially to an increasing number of studies on the issue with a wider number of participants.</s><s xml:id="_trpcmYJ">A survey of approximately 1300 patients who performed at least one televisit for clinical therapeutic management of diabetes showed an overall satisfaction with remote visits <ref type="bibr" target="#b77">[78]</ref>.</s></p><p xml:id="_xzpVYNS"><s xml:id="_CDE7nmX">Another study <ref type="bibr" target="#b78">[79]</ref> conducted on patients with both T1DM and T2DM investigated patients' satisfaction with telemedicine visits.</s><s xml:id="_MJNXF2c">Of 111 patients, 82% were pleased with the telehealth modality and 69% were interested in continuing in remote mode even after the emergency status had ceased.</s></p><p xml:id="_P9k3cxF"><s xml:id="_SASmPXb">An anonymous questionnaire <ref type="bibr" target="#b79">[80]</ref>, including questions about the use and perception of telemedicine in the management of diabetes during the COVID-19 pandemic, was administered via social media in about 40 countries.</s><s xml:id="_Um72Dng">A large percentage of responders (67%) said they had consulted their doctor remotely since the pandemic began, a significant increase from the 28% reported in a similar survey in 2020; furthermore, 83% of responders considered remote appointments useful.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3." xml:id="_dS2JxmT">Management of Diabetes Complications Risk Factors</head><p xml:id="_N9yAqHf"><s xml:id="_nff8u5g">Common cardio-metabolic risk factors in patients with diabetes are represented by hypertension and hyperlipidemia (or hypercholesterolemia) and in recent years, their coprevalence has been increasing more and more <ref type="bibr" target="#b80">[81]</ref>.</s><s xml:id="_vfU3JKV">Several interventions in telemedicine have proved to significantly improve systolic and diastolic blood pressure, triglycerides, and total cholesterol serum levels <ref type="bibr" target="#b81">[82]</ref>.</s></p><p xml:id="_sfpReZv"><s xml:id="_gAJcZWk">Telehealth could be used to help reach the objective of reducing high cholesterol level by 1. checking tolerability when starting treatment with anti-diabetic drugs; 2. real-time monitoring of LDL cholesterol levels to ensure that the ongoing anti-diabetic treatment and a proper diet are effective in controlling the disease; 3. providing opportunities to discuss cost concerns and treatment alternatives; and 4. setting goals for healthy lifestyle changes <ref type="bibr" target="#b82">[83]</ref>.</s></p><p xml:id="_UUq43uw"><s xml:id="_bMSWfSr">A RCT showed that telemedicine, through home blood pressure monitoring and remote consultations, can improve blood pressure control and treatment adherence by facilitating timely therapeutic adjustments and reducing logistical barriers to in-person care <ref type="bibr" target="#b83">[84]</ref>.</s><s xml:id="_ChBRHkd">By allowing the exchange of clinical data in either a synchronous or asynchronous way and by enabling remote visits, telemedicine enabled clinicians to make treatment changes at a distance, thus saving the time required to travel to the hospital and the waiting time prior to the visit <ref type="bibr" target="#b83">[84]</ref>.</s></p><p xml:id="_CYCjJfa"><s xml:id="_bDXy4GJ">Salisbury and colleagues <ref type="bibr" target="#b84">[85]</ref> have proved that people at high risk of cardiovascular diseases who received telehealth monitoring combined with in-office visits have slightly improved their adherence to diet, exercise and medication usage and have better satisfaction with medical care when compared with people using in-person follow up alone.</s></p><p xml:id="_p3MPprj"><s xml:id="_RRGKdQe">A recent cross-sectional study <ref type="bibr" target="#b82">[83]</ref> of 375 newly diagnosed T2DM patients has shown that telemedicine, in addition to standard antidiabetic therapy, helped reduce LDL cholesterol levels (110 mg/dL vs. 93.1 mg/dL, p &lt; 0.001).</s><s xml:id="_MRT3zu7">Notably, the intervention group relied on messaging software through which they were able to keep in touch with a diabetologist and send him/her daily photos of meals and glucose values.</s><s xml:id="_jdrrGv4">Likewise, the clinician used this application to contact patients to make therapeutic changes or provide advice on diet and lifestyle.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4." xml:id="_zR6v4pQ">Reduction in Diabetic Complications</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.1." xml:id="_WQR9CVD">Stroke and Cardiovascular Diseases</head><p xml:id="_6gUsXax"><s xml:id="_RQVGXwP">A meta-analysis conducted by Lieber and colleagues <ref type="bibr" target="#b85">[86]</ref> evaluated five clinical trials to assess the role of telemedicine in reducing HbA1c levels in post-stroke PwD.</s><s xml:id="_gxycKfW">Compliance with diabetes treatment regimens is associated with an improvement in HbA1c blood levels and therefore, a reduction in mortality and morbidity.</s><s xml:id="_4aRwyJg">The enrolled patients had a digital glucometer transmitting data to the clinic at different frequencies.</s><s xml:id="_sWxNwzP">Four out of the five trials showed a greater reduction in HbA1c in the intervention group using telemedicine than in the traditional control group.</s><s xml:id="_mwKnmFH">Furthermore, in the group receiving remote consultations, there was a greater propensity to adjust treatment to achieve better glycemic control <ref type="bibr" target="#b85">[86]</ref>.</s></p><p xml:id="_WkJxJvG"><s xml:id="_aGe923k">Moreover, another meta-analysis of 55 RCTs including people with T1DM (15 RTCs), T2DM (31 RTCs) or both types of diabetes (9 RCTs), revealed that when patients use telemedicine programs, better glucose monitoring was reached, with a substantial reduction in HbA1c levels compared to patients not using telemedicine programs <ref type="bibr" target="#b81">[82]</ref>.</s><s xml:id="_myw4mDF">A subgroup analysis according to diabetes type showed that T2DM patients had a significantly greater reduction in HbA1c than those with type 1 diabetes <ref type="bibr" target="#b81">[82]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.2." xml:id="_W5JnG56">Diabetic Neuropathy and Diabetic Foot Syndrome</head><p xml:id="_Yxh28ca"><s xml:id="_7J6GCu9">Telehealth may allow self-monitoring of foot health status for preventative, diagnostic and therapeutic purposes.</s><s xml:id="_ukxxB8d">Different approaches are available such as audio-video consultation, photographic imaging, dermal thermography and hyperspectral imaging.</s></p><p xml:id="_9MkEMjH"><s xml:id="_STHbwt9">Two RCTs <ref type="bibr" target="#b86">[87,</ref><ref type="bibr" target="#b87">88]</ref> compared the effect of phone/online platform tools on ulcer healing, amputation and death with standard care.</s><s xml:id="_nWhawu6">In detail, Rassmussen and colleagues <ref type="bibr" target="#b86">[87]</ref> evaluated the effectiveness of audio-video consultation in addition to outpatient visits on ulcer healing compared to standard care.</s><s xml:id="_JtwavBQ">Smith-StrÃ¸m et al. <ref type="bibr" target="#b87">[88]</ref> compared a weekly phone and interactive web-based ulcer record consultation in addition to outpatient visits (every 6 weeks) to standard care (outpatient visit every 2 weeks).</s><s xml:id="_UKWmyaV">Both studies found no differences between the two groups in amputation and healing time, highlighting the non-inferiority of telemedicine over its traditional counterpart.</s><s xml:id="_a46jyyF">A secondary outcome study of the Norwegian trial [89] explored the changes in self-reported quality of life and well-being in patients with diabetic foot receiving the telemedicine intervention compared to those receiving standard care and found no differences between the two groups.</s><s xml:id="_GJfuEAw">Further, patients reported outcome measures were found to be stable overtime (from baseline to several assessment time-points).</s><s xml:id="_s5f475N">In line with this evidence, two non-randomized studies <ref type="bibr" target="#b90">[90,</ref><ref type="bibr" target="#b91">91]</ref> comparing video consultation with in-person outpatient visit found no difference in ulcer healing between the two approaches.</s></p><p xml:id="_kDrpXzG"><s xml:id="_nYXpaDe">Remote ulcer area measurement from photographs could allow a continuous and reliable monitoring of ulcer evolution.</s><s xml:id="_DsBsPtC">Two studies <ref type="bibr" target="#b92">[92,</ref><ref type="bibr" target="#b93">93]</ref> revealed a strong association between remote and live assessments of ulcer area (correlation coefficient &gt; 0.95).</s><s xml:id="_ayAkJj8">Further two studies <ref type="bibr" target="#b94">[94,</ref><ref type="bibr" target="#b95">95]</ref> reported a lower inter-observer variability in ulcer area measurement from a photograph compared to live assessment.</s><s xml:id="_hKck7Ne">Hazenberg and colleagues <ref type="bibr" target="#b96">[96]</ref> found good feasibility and perceived usability of photographic ulcer assessment.</s><s xml:id="_55G8xx4">Results of their study showed a good reliability of the combination of photographic assessment and infrared thermography in the diagnosis of foot infection (sensitivity &gt; 60% and specificity &gt; 79%).</s><s xml:id="_yBgJfEN">They also found that the combined use of both techniques was more reliable than each one on its own.</s><s xml:id="_wmtErth">Foot temperature alteration in DFS are the results of compromised thermoregulation due to both peripheral arterial disease and neuropathy.</s><s xml:id="_fCz5kjE">It can be estimated through different techniques: temperature sensors based on thermistor, infrared thermography and liquid-crystal thermography.</s><s xml:id="_DZD6g2f">Four RCTs <ref type="bibr" target="#b97">[97]</ref><ref type="bibr" target="#b98">[98]</ref><ref type="bibr" target="#b99">[99]</ref><ref type="bibr">[100]</ref> explored the effectiveness of infrared thermography in ulcer prevention.</s><s xml:id="_CP8Yf3p">Patients allocated to the intervention group were instructed to measure foot temperature in six different locations per foot, daily.</s><s xml:id="_zUwjrEx">Patients were invited to contact the HCP in case they revealed a 2.2 â¢ C temperature difference between the left and the right foot in the same location for at least two consecutive days.</s><s xml:id="_NgwHB9J">Patients in the control group received traditional monitoring that did not include temperature monitoring.</s><s xml:id="_csMf8Ea">Three studies out of four <ref type="bibr" target="#b97">[97]</ref><ref type="bibr" target="#b98">[98]</ref><ref type="bibr" target="#b99">[99]</ref>, including, respectively, 85, 225 and 173 patients found a significant reduction in ulceration or recurrent ulcer rate in the intervention group compared to the control one (respectively: p = 0.01; p = 0.038; p = 0.0046).</s><s xml:id="_atXkJFM">The fourth study [100] did not find any significant difference between the two groups (p = 0.532); however, the sample size of the patients was not as large as that reported in the other studies <ref type="bibr">(45 patients)</ref>.</s></p><p xml:id="_e7tcBxr"><s xml:id="_2UWbTGF">The effectiveness of liquid-crystal thermography in ulcer prevention and diagnosis was explored only in three small clinical studies <ref type="bibr">[101]</ref><ref type="bibr">[102]</ref><ref type="bibr">[103]</ref>.</s><s xml:id="_yntYAwd">No studies are available on patients suffering from diabetes, suggesting a low applicability.</s><s xml:id="_6D3c4zP">Therefore, available data does not allow any reliable conclusion.</s><s xml:id="_wWyBwKH">Only one study [104] explored the diagnostic effectiveness of a wireless temperature sensor based on a thermistor and found that using a temperature difference between the two sides of 2.2 â¢ C as cut off, the tool correctly recognized 97% of diabetic foot ulcers.</s><s xml:id="_YBn4GXn">However, the authors also found a high rate of false-positives (specificity of 43%).</s><s xml:id="_6fnZKSj">Even in this case the available data did not allow the researchers to reach a conclusion.</s></p><p xml:id="_V8Rfmyf"><s xml:id="_YqcgEX8">Hyperspectral imaging is a technique that measures tissue oxygenation levels and generate maps of microcirculatory changes through the collection and processing of information of the near-infrared range of the electromagnetic spectrum.</s><s xml:id="_RdFFAuM">Four case-control studies [105-108] on ulcers before healing revealed a reduction in oxyhemoglobin level in healed ulcers compared to no change in oxyhemoglobin level in non-healed ulcers.</s><s xml:id="_Xu59J3m">Conversely, three case-control studies [109-111] explored the specificity and sensitivity of hyperspectral imaging for prediction of ulcer healing.</s><s xml:id="_4h34AFa">The first two [110,111] found a sensitivity, respectively, of 93% and 80% and specificity of 86 and 74% to predict ulcers healing in 24 weeks; conversely, the third one [109] found a sensitivity of 90% and a specificity of 86% in one month.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.3." xml:id="_jKZgbhu">Mental Illness</head><p xml:id="_nAqEbcJ"><s xml:id="_CBy3Pn7">Mental illness is considered to play a key role among the risk factors of chronic diseases; comorbid depression predicts the onset and progression of several chronic diseases.</s><s xml:id="_zTTSh3v">Indeed, having strong coping mechanisms such as emotional expression, acceptance of the condition and problem solving was associated with a better quality of life and lower HbA1c levels <ref type="bibr">[112]</ref>.</s><s xml:id="_azqBTyU">Conversely, low scores on the PROMIS, a questionnaire assessing several aspects of the quality of life, were associated with depression and less frequent blood glucose checks <ref type="bibr">[113]</ref>.</s></p><p xml:id="_VaQDnJG"><s xml:id="_kUMagN4">A systematic review [114] including seventeen RCTs evaluated the effectiveness of digital tools in mental illness management in chronic diseases such as cardiovascular diseases, chronic obstructive pulmonary disease (COPD), stroke and diabetes.</s><s xml:id="_3BR43eD">The studies included in the review described different types of tele-interventions; several offered digital educational content specific to the disease along with lifestyle advice and recommendations; others included telemonitoring applications for symptoms of depression; finally, some also provided remote psychotherapy interventions.</s><s xml:id="_5X7AkVA">Study results revealed a moderate beneficial effect on depression outcomes.</s><s xml:id="_qQ23mbz">Moreover, patients suffering from both COPD and diabetes received a higher benefit from the interventions compared to those affected by cardiovascular diseases and stroke.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4." xml:id="_r6XPaM6">Conclusions</head><p xml:id="_4dFuWYV"><s xml:id="_gP3TWwQ">In this narrative review, we have highlighted the established yet ever-growing role of telemedicine in the management of diabetes, covering daily management of risk factors and complications and the administration of antidiabetic therapy.</s><s xml:id="_xNZmaV3">The presented studies revealed an overall satisfaction among PwD and their caregivers regarding remote telemedicine management.</s><s xml:id="_MDZvTCu">Telehealth has demonstrated the capability to provide a fully patient-centered approach to disease management through highly personalized management plans.</s><s xml:id="_uee9hGe">This has led to improved adherence to appropriate therapy and lifestyle, ultimately contributing to better quality of life.</s></p><p xml:id="_f5XeTDf"><s xml:id="_eW4BQZk">Whilst telemedicine has clearly a wide spectrum of potential benefits, it also presents challenges that must be addressed.</s><s xml:id="_84B8qWs">Firstly, many elements of the traditional approach may be missing.</s><s xml:id="_ngWDjrV">Physical presence and emotional connection may be limited by remote visits, and a complete objective examination may not always be possible due to technological constraints.</s><s xml:id="_bzDhb9a">Furthermore, real-world implementation faces additional barriers, including disparities in access to digital tools, particularly in rural or underserved areas.</s><s xml:id="_XnWnT95">Inadequate broadband coverage and unaffordable costs of digital tools may prevent equitable access to telemedicine, reinforcing the existing disparities known as the digital divide.</s><s xml:id="_yGj7byX">Moreover, limited digital literacy, whether due to age, educational background, or sensory or cognitive impairments, can represent a significant barrier to telemedicine access.</s><s xml:id="_4ENnTXK">Concerns about data privacy, cybersecurity, and unclear reimbursement policies further complicate integration into standard care models.</s><s xml:id="_GNVaXRp">Finally, other limitations are represented by the lack of standardized protocols of intervention, the lack of regulation and reimbursement guidelines and the limited validation of the digital devices in non-English languages.</s><s xml:id="_5mr9GSd">Although telemedicine is already widely implemented, its future potential lies in enabling fully patient-centered care, bringing diabetes management closer to the patient's home.</s></p><p xml:id="_eKCsbdW"><s xml:id="_8bvf6Dj">At present telemedicine represents a valuable tool for managing diabetes and its related risk factors and complications.</s><s xml:id="_6RKaM7Y">However certain aspects of care may still benefit from in-person interaction.</s><s xml:id="_u7Dgf7V">For now, the best approach remains a balanced integration of telemedicine and face-to-face consultations to achieve the best possible treatment and an improved quality of life.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ZfEfdyw">Supplementary Materials:</head><p xml:id="_DebUPbQ"><s xml:id="_X2UNxtV">The following supporting information can be downloaded at: <ref type="url" target="https://www.mdpi.com/article/10.3390/jcm14124240/s1">https:  //www.mdpi.com/article/10.3390/jcm14124240/s1</ref>,</s><s xml:id="_ADQgCUN">Table <ref type="table">S1</ref>: Digital health interventions in diabetes care and associated outcomes.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_PYsQcsr"><s xml:id="_DGg5SYG">Figure1.</s><s xml:id="_pqkfgVf">Conceptual framework of a digital virtual diabetes clinic.</s><s xml:id="_C4kvEdD">The figure illustrates the conceptual framework of a digital, virtual diabetes clinic, highlighting the integration of innovative digital health technologies for effective and efficient diabetes management.</s><s xml:id="_NG4Yacp">Through at-home blood glucose monitoring, telemedicine consultations, and personalized digital interventions, the digital virtual clinic offers a comprehensive approach to diabetes management, enhancing patient engagement and clinical outcomes.</s></p></div></figDesc><graphic coords="2,168.44,432.57,331.44,186.42" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Author</head><figDesc><div><p xml:id="_GdG3Pvp"><s xml:id="_8cUSyQ8">Contributions: Conceptualization, L.L. and M.I.M.; methodology, E.M. and G.A.; data curation, E.M., G.A. and G.M.; writing-original draft preparation, E.M., G.A., G.M., P.C., M.L., E.R.,</s></p></div></figDesc></figure>
		</body>
		<back>


			<div type="funding">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_rmUuuYQ"><p xml:id="_bFHJt52"><s xml:id="_tVdmHcG">Funding: This research received no external funding.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_p4MQmSK">Conflicts of Interest:</head><p xml:id="_STUWhFc"><s xml:id="_6ZWRAtD">The authors declare no conflicts of interest.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FS7AHMY">Abbreviations</head><p xml:id="_egS7ufn"><s xml:id="_HDeMTBn">The following abbreviations are used in this manuscript:</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_a7rvTES">Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021</title>
		<author>
			<persName><surname>Gbd</surname></persName>
			<affiliation>
				<orgName type="collaboration">Diabetes Collaborators</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1016/S0140-6736(23)01301-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aXrWX4u">Lancet</title>
		<imprint>
			<biblScope unit="volume">402</biblScope>
			<biblScope unit="page" from="203" to="234" />
			<date type="published" when="2021">2021. 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023, 402, 203-234. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_3RFb9qW">Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Aroda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Gabbay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Maruthur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Rosas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Del Prato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mathieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mingrone</surname></persName>
		</author>
		<idno type="DOI">10.2337/dci22-0034</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Mfj5f4J">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="2753" to="2786" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Davies, M.J.; Aroda, V.R.; Collins, B.S.; Gabbay, R.A.; Green, J.; Maruthur, N.M.; Rosas, S.E.; Del Prato, S.; Mathieu, C.; Mingrone, G.; et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2022, 45, 2753-2786. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_Te2HqZu">Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Giugliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Maiorino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bellastella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Esposito</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40618-018-0951-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rbgDqca">J. Endocrinol. Invest</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="495" to="503" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Giugliano, D.; Maiorino, M.I.; Bellastella, G.; Esposito, K. Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes. J. Endocrinol. Invest. 2019, 42, 495-503. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_mcVEGj2">Shared decision making in endocrinology: Present and future directions</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rodriguez-Gutierrez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Gionfriddo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Ospina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Maraka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tamhane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Montori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Brito</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2213-8587(15)00468-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4FzE65X">Lancet Diabetes Endocrinol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="706" to="716" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rodriguez-Gutierrez, R.; Gionfriddo, M.R.; Ospina, N.S.; Maraka, S.; Tamhane, S.; Montori, V.M.; Brito, J.P. Shared decision making in endocrinology: Present and future directions. Lancet Diabetes Endocrinol. 2016, 4, 706-716. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_nRrM67m">The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction</title>
		<author>
			<persName><forename type="first">M</forename><surname>Phillip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Close</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Danne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Heinemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Kovatchev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Laffel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Mohan</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2020.0375</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Fbkm8VE">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="146" to="154" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Phillip, M.; Bergenstal, R.M.; Close, K.L.; Danne, T.; Garg, S.K.; Heinemann, L.; Hirsch, I.B.; Kovatchev, B.P.; Laffel, L.M.; Mohan, V.; et al. The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction. Diabetes Technol. Ther. 2021, 23, 146-154. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_qHMyzrq">Psychosocial problems and barriers to improved diabetes management: Results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Peyrot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lauritzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Snoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Skovlund</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1464-5491.2005.01644.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NVK7WKV">Diabet. Med</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1379" to="1385" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Peyrot, M.; Rubin, R.R.; Lauritzen, T.; Snoek, F.J.; Matthews, D.R.; Skovlund, S.E. Psychosocial problems and barriers to improved diabetes management: Results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet. Med. 2005, 22, 1379-1385. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_JrgS5jj">Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care</title>
		<author>
			<persName><forename type="first">M</forename><surname>Peyrot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lauritzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Snoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Skovlund</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2012.11.016</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xVw43Z6">Diabetes Res. Clin. Pract</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="174" to="184" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Peyrot, M.; Rubin, R.R.; Lauritzen, T.; Snoek, F.J.; Matthews, D.R.; Skovlund, S.E. Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Res. Clin. Pract. 2013, 99, 174-184. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_CsyRUhZ">Identifying the unmet needs of individuals with Type 2 diabetes: An international web-based survey</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Raposo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Shestakova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Court</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Mayorov</surname></persName>
		</author>
		<idno type="DOI">10.2217/cer-2020-0271</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v7gsdpm">J. Comp. Eff. Res</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="613" to="624" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Raposo, J.F.; Shestakova, M.V.; Lu, J.; Court, E.; Mayorov, A.Y. Identifying the unmet needs of individuals with Type 2 diabetes: An international web-based survey. J. Comp. Eff. Res. 2021, 10, 613-624. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_4k4N5AF">Digital Health Technologies Enabling Partnerships in Chronic Care Management: Scoping Review</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wannheden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ãberg-Wennerholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dahlberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ã</forename><surname>RevenÃ¤s</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Eftimovska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brommels</surname></persName>
		</author>
		<idno type="DOI">10.2196/38980</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WUcvV6V">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">38980</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wannheden, C.; Ãberg-Wennerholm, M.; Dahlberg, M.; RevenÃ¤s, Ã.; Tolf, S.; Eftimovska, E.; Brommels, M. Digital Health Technologies Enabling Partnerships in Chronic Care Management: Scoping Review. J. Med. Internet Res. 2022, 24, e38980. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_PgEcJQA">Tele-health Start-Up and Resource Guide, Version 1.1</title>
		<idno type="DOI">10.1089/tmj.2008.8477</idno>
		<ptr target="https://www.healthit.gov/sites/default/files/playbook/pdf/telehealth-startup-and-resource-guide.pdf" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_qJ2TvUd">Telling and gpTRAC (Great Plains Tele-health Resource &amp; Assistance Center)</title>
		<imprint>
			<date type="published" when="2010-10-10">October 2010. 10 April 2025</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Telling and gpTRAC (Great Plains Tele-health Resource &amp; Assistance Center). Tele-health Start-Up and Resource Guide, Version 1.1, October 2010. Available online: https://www.healthit.gov/sites/default/files/playbook/pdf/telehealth-startup- and-resource-guide.pdf (accessed on 10 April 2025).</note>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<idno type="DOI">10.4081/mem.2021.945</idno>
		<ptr target="https://www.salute.gov.it/new/it/tema/telemedicina/linee-di-indirizzo-nazionali-sulla-telemedicina/" />
		<title level="m" xml:id="_xUZNX74">Telemedicina Linee di Indirizzo Nazionali</title>
		<imprint>
			<publisher>Ministero della Salute</publisher>
			<date type="published" when="2025-04-10">10 April 2025</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ministero della Salute. Telemedicina Linee di Indirizzo Nazionali. Available online: https://www.salute.gov.it/new/it/tema/ telemedicina/linee-di-indirizzo-nazionali-sulla-telemedicina/ (accessed on 10 April 2025).</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_Fw4U6VJ">Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review</title>
		<author>
			<persName><forename type="first">C</forename><surname>Eberle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stichling</surname></persName>
		</author>
		<idno type="DOI">10.2196/23244</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cKgF9MX">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">23244</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Eberle, C.; Stichling, S. Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review. J. Med. Internet Res. 2021, 23, e23244. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_R5ng2pZ">Enablers and barriers to using two-way information technology in the management of adults with diabetes: A descriptive systematic review</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Perrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Kingsley</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x17699990</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UdYyHrh">J. Telemed. Telecare</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="319" to="340" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Macdonald, E.M.; Perrin, B.M.; Kingsley, M.I. Enablers and barriers to using two-way information technology in the management of adults with diabetes: A descriptive systematic review. J. Telemed. Telecare. 2018, 24, 319-340. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_vj8XcxM">Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials</title>
		<author>
			<persName><forename type="first">H</forename><surname>Tchero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kangambega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Briatte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brunet-Houdard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Retali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rusch</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2018.0128</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ckFqahy">Telemed. J. E Health</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="569" to="583" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tchero, H.; Kangambega, P.; Briatte, C.; Brunet-Houdard, S.; Retali, G.R.; Rusch, E. Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials. Telemed. J. E Health 2019, 25, 569-583. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_5ZvtCC5">Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W H</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2018.0098</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qVC37cM">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="492" to="500" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee, J.Y.; Lee, S.W.H. Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review. Diabetes Technol. Ther. 2018, 20, 492-500. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_eZT3cwY">Care Coordination/Home Telehealth: The systematic implementation of health informatics, home telehealth, and disease management to support the care of veteran patients with chronic conditions</title>
		<author>
			<persName><forename type="first">A</forename><surname>Darkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kobb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Edmonson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wakefield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Lancaster</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2008.0021</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XDkUJZp">Telemed. J. E Health</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1118" to="1126" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Darkins, A.; Ryan, P.; Kobb, R.; Foster, L.; Edmonson, E.; Wakefield, B.; Lancaster, A.E. Care Coordination/Home Telehealth: The systematic implementation of health informatics, home telehealth, and disease management to support the care of veteran patients with chronic conditions. Telemed. J. E Health 2008, 14, 1118-1126. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_y3hQ5yb">Telemedicine and advances in urban and rural healthcare delivery in Africa</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mars</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pcad.2013.10.006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vzFrga4">Prog. Cardiovasc. Dis</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="326" to="335" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mars, M. Telemedicine and advances in urban and rural healthcare delivery in Africa. Prog. Cardiovasc. Dis. 2013, 56, 326-335. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_DXTtKwM">International Consensus on Use of Continuous Glucose Monitoring</title>
		<author>
			<persName><forename type="first">T</forename><surname>Danne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nimri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Battelino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Close</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Devries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Heinemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Amiel</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc17-1600</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Cyr7efy">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1631" to="1640" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Danne, T.; Nimri, R.; Battelino, T.; Bergenstal, R.M.; Close, K.L.; DeVries, J.H.; Garg, S.; Heinemann, L.; Hirsch, I.; Amiel, S.A.; et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017, 40, 1631-1640. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_hmtGUYt">Diabetes Technology: Standards of Care in Diabetes-2024</title>
		<idno type="DOI">10.2337/dc24-s007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_f73RU8J">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="126" to="S144" />
			<date type="published" when="2024">2024</date>
			<publisher>American Diabetes Association Professional Practice Committee</publisher>
		</imprint>
	</monogr>
	<note>Suppl. S1</note>
	<note type="raw_reference">American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes-2024. Diabetes Care 2024, 47 (Suppl. S1), S126-S144. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_HyNN5cs">Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range</title>
		<author>
			<persName><forename type="first">T</forename><surname>Battelino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Danne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Amiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Biester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Buckingham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Cefalu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Close</surname></persName>
		</author>
		<idno type="DOI">10.2337/dci19-0028</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bMTvAHz">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1593" to="1603" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Battelino, T.; Danne, T.; Bergenstal, R.M.; Amiel, S.A.; Beck, R.; Biester, T.; Bosi, E.; Buckingham, B.A.; Cefalu, W.T.; Close, K.L.; et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019, 42, 1593-1603. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_AtJGgqr">Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">V</forename><surname>Tamborlane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Bode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Buckingham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Chase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Clemons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fiallo-Scharer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Gilliam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Hirsch</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa0805017</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_faPrPuF">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="page" from="1464" to="1476" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tamborlane, W.V.; Beck, R.W.; Bode, B.W.; Buckingham, B.; Chase, H.P.; Clemons, R.; Fiallo-Scharer, R.; Fox, L.A.; Gilliam, L.K.; Hirsch, I.B.; et al. Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N. Engl. J. Med. 2008, 359, 1464-1476.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_FbQyvqd">Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes</title>
		<author>
			<persName><forename type="first">T</forename><surname>Battelino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Phillip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bratina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nimri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Oskarsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bolinder</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc10-1989</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JxjyTD5">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="795" to="800" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Battelino, T.; Phillip, M.; Bratina, N.; Nimri, R.; Oskarsson, P.; Bolinder, J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011, 34, 795-800. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_KjUmm8Y">The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Battelino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Conget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>SchÃ¼tz-Fuhrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hommel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hoogma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schierloh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sulli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bolinder</surname></persName>
		</author>
		<author>
			<persName><surname>Switch Study</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00125-012-2708-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KUrMagU">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="3155" to="3162" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Battelino, T.; Conget, I.; Olsen, B.; SchÃ¼tz-Fuhrmann, I.; Hommel, E.; Hoogma, R.; Schierloh, U.; Sulli, N.; Bolinder, J.; SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial. Diabetologia 2012, 55, 3155-3162. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_9Zjztc6">Recovery of hypoglycemia awareness in long-standing type 1 diabetes: A multicenter 2 Ã 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Little</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Leelarathna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Walkinshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Chapple</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lubina-Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Chadwick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barendse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Stocken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brennand</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc14-0030</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gRZS46J">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2114" to="2122" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Little, S.A.; Leelarathna, L.; Walkinshaw, E.; Tan, H.K.; Chapple, O.; Lubina-Solomon, A.; Chadwick, T.J.; Barendse, S.; Stocken, D.D.; Brennand, C.; et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: A multicenter 2 Ã 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014, 37, 2114-2122. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_UkyJcEW">Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): A randomised, open-label, crossover trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Van Beers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Devries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kleijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Smits</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Geelhoed-Duijvestijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Diamant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Snoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>SernÃ©</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2213-8587(16)30193-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eA8nkvj">Lancet Diabetes Endocrinol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="893" to="902" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Beers, C.A.; DeVries, J.H.; Kleijer, S.J.; Smits, M.M.; Geelhoed-Duijvestijn, P.H.; Kramer, M.H.; Diamant, M.; Snoek, F.J.; SernÃ©, E.H. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): A randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016, 4, 893-902. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_ZqzpzAz">Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Riddlesworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ruedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Haller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kollman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kruger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Mcgill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Polonsky</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2016.19975</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_W5wJ4jd">JAMA</title>
		<imprint>
			<biblScope unit="volume">317</biblScope>
			<biblScope unit="page" from="371" to="378" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beck, R.W.; Riddlesworth, T.; Ruedy, K.; Ahmann, A.; Bergenstal, R.; Haller, S.; Kollman, C.; Kruger, D.; McGill, J.B.; Polonsky, W.; et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. JAMA 2017, 317, 371-378. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_W2dkvYk">Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Riddlesworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ruedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Haller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kruger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Mcgill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Polonsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aronoff</surname></persName>
		</author>
		<idno type="DOI">10.7326/M16-2855</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cg4Wqxu">Ann. Intern. Med</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="365" to="374" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beck, R.W.; Riddlesworth, T.D.; Ruedy, K.; Ahmann, A.; Haller, S.; Kruger, D.; McGill, J.B.; Polonsky, W.; Price, D.; Aronoff, S.; et al. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial. Ann. Intern. Med. 2017, 167, 365-374. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_gWEpkEz">Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): A multicentre, randomised controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><surname>Heinemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Freckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ehrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Faber-Heinemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guerra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Waldenmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hermanns</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(18)30297-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8Z7XGHK">Lancet</title>
		<imprint>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="page" from="1367" to="1377" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Heinemann, L.; Freckmann, G.; Ehrmann, D.; Faber-Heinemann, G.; Guerra, S.; Waldenmaier, D.; Hermanns, N. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): A multicentre, randomised controlled trial. Lancet 2018, 391, 1367-1377. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_weWPEuZ">Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) Study Group. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes: A Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Pratley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Kanapka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Ahmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aleppo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bhargava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chaytor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename></persName>
		</author>
		<idno type="DOI">10.1001/jama.2020.6928</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Nabjsxg">JAMA</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="2397" to="2406" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pratley, R.E.; Kanapka, L.G.; M.R.; Ahmann, A.; Aleppo, G.; Beck, R.; Bhargava, A.; Bode, B.W.; Carlson, A.; Chaytor, N.S.; et al. Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) Study Group. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes: A Randomized Clinical Trial. JAMA 2020, 323, 2397-2406. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_qcmQ2e9">Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin: A Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Martens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Ruedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Calhoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pop-Busui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Philis-Tsimikas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Umpierrez</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2021.7444</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cRTrTDR">JAMA</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="2262" to="2272" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Martens, T.; Beck, R.W.; Bailey, R.; Ruedy, K.J.; Calhoun, P.; Peters, A.L.; Pop-Busui, R.; Philis-Tsimikas, A.; Bao, S.; Umpierrez, G.; et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin: A Randomized Clinical Trial. JAMA 2021, 325, 2262-2272. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_A3RPmcs">Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Meta-analysis of randomised controlled trials using individual patient data</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Pickup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Sutton</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.d3805</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fjC2nNk">BMJ</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page">3805</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pickup, J.C.; Freeman, S.C.; Sutton, A.J. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Meta-analysis of randomised controlled trials using individual patient data. BMJ 2011, 343, d3805. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_WKeJRWp">Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Shah</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2021.0007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yNsbSnQ">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="S34" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jackson, M.A.; Ahmann, A.; Shah, V.N. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring. Diabetes Technol Ther. 2021, 23 (S1), S27-S34. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_2ssJFT4">Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): A multicentre international randomised controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Feig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Donovan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Corcoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Amiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Asztalos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F R</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De Leiva</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(17)32400-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HYSpPVs">Lancet</title>
		<imprint>
			<biblScope unit="volume">390</biblScope>
			<biblScope unit="page" from="2347" to="2359" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Feig, D.S.; Donovan, L.E.; Corcoy, R.; Murphy, K.E.; Amiel, S.A.; Hunt, K.F.; Asztalos, E.; Barrett, J.F.R.; Sanchez, J.J.; de Leiva, A.; et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): A multicentre international randomised controlled trial. Lancet 2017, 390, 2347-2359. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_hBvZJYp">Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Leelarathna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Neupane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rayman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lumley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cranston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Narendran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Barnard-Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Sutton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Elliott</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa2205650</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nhHmS9K">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">387</biblScope>
			<biblScope unit="page" from="1477" to="1487" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leelarathna, L.; Evans, M.L.; Neupane, S.; Rayman, G.; Lumley, S.; Cranston, I.; Narendran, P.; Barnard-Kelly, K.; Sutton, C.J.; Elliott, R.A.; et al. Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes. N. Engl. J. Med. 2022, 387, 1477-1487. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_d9sSzJq">Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: A Multicenter, Open-Label Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Haak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hanaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ajjan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hermanns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Riveline</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rayman</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13300-016-0223-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EjhbthX">Diabetes Ther</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="55" to="73" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haak, T.; Hanaire, H.; Ajjan, R.; Hermanns, N.; Riveline, J.P.; Rayman, G. Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: A Multicenter, Open-Label Randomized Controlled Trial. Diabetes Ther. 2017, 8, 55-73. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_w8VSZTF">Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yaron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Roitman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Aharon-Hananel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Landau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ganz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Yanuv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rozenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ish-Shalom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Singer</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc18-0166</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tGBagez">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1178" to="1184" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yaron, M.; Roitman, E.; Aharon-Hananel, G.; Landau, Z.; Ganz, T.; Yanuv, I.; Rozenberg, A.; Karp, M.; Ish-Shalom, M.; Singer, J.; et al. Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes. Diabetes Care 2019, 42, 1178-1184. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_eCVaUy7">Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data from People with Diabetes on Intensive Insulin Therapy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Maddaloni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Coraggio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pieralice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carlone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pozzilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Buzzetti</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc20-0954</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PnBBRWV">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="86" to="e87" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maddaloni, E.; Coraggio, L.; Pieralice, S.; Carlone, A.; Pozzilli, P.; Buzzetti, R. Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data from People with Diabetes on Intensive Insulin Therapy. Diabetes Care 2020, 43, e86-e87. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_h3rh3mm">Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes</title>
		<author>
			<persName><forename type="first">B</forename><surname>Capaldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Annuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Creanza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Giglio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Angelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lupoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Masulli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Riccardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Rivellese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bozzetto</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc20-1127</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2aca9v5">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="88" to="e89" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Capaldo, B.; Annuzzi, G.; Creanza, A.; Giglio, C.; De Angelis, R.; Lupoli, R.; Masulli, M.; Riccardi, G.; Rivellese, A.A.; Bozzetto, L. Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes. Diabetes Care 2020, 43, e88-e89. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_XvM8aTN">Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Maiorino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Signoriello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chiodini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bellastella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Scappaticcio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Longo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Giugliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Esposito</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc19-1459</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Rs84ZNp">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1146" to="1156" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maiorino, M.I.; Signoriello, S.; Maio, A.; Chiodini, P.; Bellastella, G.; Scappaticcio, L.; Longo, M.; Giugliano, D.; Esposito, K. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020, 43, 1146-1156. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_knjqDkt">An. updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Maiorino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Buzzetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Irace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Laviola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Napoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pitocco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Esposito</surname></persName>
		</author>
		<author>
			<persName><surname>Cgm</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12020-023-03473-w</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vVZ6eMa">Endocrine</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="215" to="225" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maiorino, M.I.; Buzzetti, R.; Irace, C.; Laviola, L.; Napoli, N.; Pitocco, D.; Esposito, K. LIVE CGM working group. An. updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes. Endocrine 2023, 82, 215-225. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_NbbMUTE">Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen</title>
		<author>
			<persName><forename type="first">P</forename><surname>Adolfsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Hartvig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kaas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>MÃ¸ller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hellman</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2019.0411</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_485QuqB">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="709" to="718" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Adolfsson, P.; Hartvig, N.V.; Kaas, A.; MÃ¸ller, J.B.; Hellman, J. Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen. Diabetes Technol. Ther. 2020, 22, 709-718. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_U59X4GY">Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meadows</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wolpert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Polonsky</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2021.0239</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qaTYYGg">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="61" to="66" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Edwards, S.; He, X.; Wang, W.; Poon, J.L.; Meadows, E.; Price, D.; Johnson, J.; Wolpert, H.; Polonsky, W. Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes. Diabetes Technol. Ther. 2022, 24, 61-66. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_adaAVpy">Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Jendle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ã</forename><surname>Ericsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gundgaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>MÃ¸ller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Valentine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hunt</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13300-020-00980-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_S4bC5n7">Diabetes Ther</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="373" to="388" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jendle, J.; Ericsson, Ã.; Gundgaard, J.; MÃ¸ller, J.B.; Valentine, W.J.; Hunt, B. Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis. Diabetes Ther. 2021, 12, 373-388. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_m847JDh">Potential cost savings in the United States from a reduction in sensor-detected severe hypoglycemia among users of the InPen smart insulin pen system</title>
		<author>
			<persName><forename type="first">A</forename><surname>Chien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Thanasekaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gaetano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Im</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wherry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Macleod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Vigersky</surname></persName>
		</author>
		<idno type="DOI">10.18553/jmcp.2023.22283</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xe4WTKF">J. Manag. Care Spec. Pharm</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="285" to="292" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chien, A.; Thanasekaran, S.; Gaetano, A.; Im, G.; Wherry, K.; MacLeod, J.; Vigersky, R.A. Potential cost savings in the United States from a reduction in sensor-detected severe hypoglycemia among users of the InPen smart insulin pen system. J. Manag. Care Spec. Pharm. 2023, 29, 285-292. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_rAUM9ZV">Threshold-based insulin-pump interruption for reduction of hypoglycemia</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Klonoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Bode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Meredith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Slover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Ahmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Welsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Study</forename><surname>Aspire In-Home</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1303576</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_n94w3qF">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="224" to="232" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bergenstal, R.M.; Klonoff, D.C.; Garg, S.K.; Bode, B.W.; Meredith, M.; Slover, R.H.; Ahmann, A.J.; Welsh, J.B.; Lee, S.W.; Kaufman, F.R. ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N. Engl. J. Med. 2013, 369, 224-232. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_2kQc7Ee">Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children with Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Forlenza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Buckingham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Pinsker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cengiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Wadwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ekhlaspour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Church</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Weinzimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jost</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc18-0771</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VyyJZ93">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="2155" to="2161" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Forlenza, G.P.; Li, Z.; Buckingham, B.A.; Pinsker, J.E.; Cengiz, E.; Wadwa, R.P.; Ekhlaspour, L.; Church, M.M.; Weinzimer, S.A.; Jost, E.; et al. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children with Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Diabetes Care 2018, 41, 2155-2161. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_85phzZr">Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients with Type 1 Diabetes</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Weinzimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Buckingham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Bode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">V</forename><surname>Tamborlane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Kaufman</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2016.11708</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zgWGVSS">JAMA</title>
		<imprint>
			<biblScope unit="volume">316</biblScope>
			<biblScope unit="page" from="1407" to="1408" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bergenstal, R.M.; Garg, S.; Weinzimer, S.A.; Buckingham, B.A.; Bode, B.W.; Tamborlane, W.V.; Kaufman, F.R. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients with Type 1 Diabetes. JAMA 2016, 316, 1407-1408.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title/>
		<idno type="DOI">10.1001/jama.2016.11708</idno>
		<imprint/>
	</monogr>
	<note type="raw_reference">CrossRef</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_AkupAGm">APCam11 Consortium. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: A multicentre, 12-week randomised trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tauschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thabit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bally</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hartnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Wilinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ruan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sibayan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kollman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cheng</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(18)31947-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mfnuSAZ">Lancet</title>
		<imprint>
			<biblScope unit="volume">392</biblScope>
			<biblScope unit="page" from="1321" to="1329" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tauschmann, M.; Thabit, H.; Bally, L.; Allen, J.M.; Hartnell, S.; Wilinska, M.E.; Ruan, Y.; Sibayan, J.; Kollman, C.; Cheng, P.; et al. APCam11 Consortium. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: A multicentre, 12-week randomised trial. Lancet 2018, 392, 1321-1329. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_g9bmfUr">A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Breton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Kanapka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ekhlaspour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Forlenza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cengiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schoelwer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Ruedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Carria</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa2004736</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_m6BTY2V">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">383</biblScope>
			<biblScope unit="page" from="836" to="845" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Breton, M.D.; Kanapka, L.G.; Beck, R.W.; Ekhlaspour, L.; Forlenza, G.P.; Cengiz, E.; Schoelwer, M.; Ruedy, K.J.; Jost, E.; Carria, L.; et al. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. N. Engl. J. Med. 2020, 383, 836-845. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_VE8eFQc">Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ware</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Boughton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Wilinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hartnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thankamony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>De Beaufort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schierloh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>FrÃ¶hlich-Reiterer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Mader</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa2111673</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3EJMrjj">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">386</biblScope>
			<biblScope unit="page" from="209" to="219" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ware, J.; Allen, J.M.; Boughton, C.K.; Wilinska, M.E.; Hartnell, S.; Thankamony, A.; de Beaufort, C.; Schierloh, U.; FrÃ¶hlich-Reiterer, E.; Mader, J.K.; et al. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes. N. Engl. J. Med. 2022, 386, 209-219. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_fvx22ya">Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: A systematic review and meta-analysis of outpatient randomised controlled trials</title>
		<author>
			<persName><forename type="first">A</forename><surname>Weisman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cardinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Perkins</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2213-8587(17)30167-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XajbhAf">Lancet Diabetes Endocrinol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="501" to="512" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weisman, A.; Bai, J.W.; Cardinez, M.; Kramer, C.K.; Perkins, B.A. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: A systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 2017, 5, 501-512. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_wPnXTG8">Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bekiari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kitsios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thabit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tauschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Athanasiadou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Karagiannis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Haidich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hovorka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tsapas</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.k1310</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RjvMQqt">BMJ</title>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page">1310</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bekiari, E.; Kitsios, K.; Thabit, H.; Tauschmann, M.; Athanasiadou, E.; Karagiannis, T.; Haidich, A.B.; Hovorka, R.; Tsapas, A. Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis. BMJ 2018, 361, k1310. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_C6pkyJe">Automated insulin delivery: Benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sherr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Heinemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bruttomesso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hanaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Holl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Evans</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00125-022-05744-z</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nPhFXQh">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="3" to="22" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sherr, J.L.; Heinemann, L.; Fleming, G.A.; Bergenstal, R.M.; Bruttomesso, D.; Hanaire, H.; Holl, R.W.; Petrie, J.R.; Peters, A.L.; Evans, M. Automated insulin delivery: Benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia 2023, 66, 3-22. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_uEsuzTW">Adjust to target in type 2 diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Powers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wynne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vlajnic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rendell</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc07-2137</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gXHmmhu">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1305" to="1310" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bergenstal, R.M.; Johnson, M.; Powers, M.A.; Wynne, A.; Vlajnic, A.; Hollander, P.; Rendell, M. Adjust to target in type 2 diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 2008, 31, 1305-1310. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_4xrzDMR">Behavior change techniques in top-ranked mobile apps for physical activity</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Conroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Maher</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2014.01.010</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cpWJpp9">Am. J. Prev. Med</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="649" to="652" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Conroy, D.E.; Yang, C.H.; Maher, J.P. Behavior change techniques in top-ranked mobile apps for physical activity. Am. J. Prev. Med. 2014, 46, 649-652. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_2tNpgH6">A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Goyal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Nunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rotondi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Couperthwaite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Reiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Simone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Katzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cafazzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Palmert</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.7336</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qHcPd2E">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goyal, S.; Nunn, C.A.; Rotondi, M.; Couperthwaite, A.B.; Reiser, S.; Simone, A.; Katzman, D.K.; Cafazzo, J.A.; Palmert, M.R. A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled Trial. JMIR Mhealth Uhealth 2017, 5, e82. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_gaEDR9b">Feasibility and Impact of Remote Glucose Monitoring Among Patients With Newly Diagnosed Type 1 Diabetes: Single-Center Pilot Study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Crossen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Romero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reggiardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Michel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Glaser</surname></persName>
		</author>
		<idno type="DOI">10.2196/33639</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jh6NT6F">JMIR Diabetes</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">33639</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Crossen, S.; Romero, C.; Reggiardo, A.; Michel, J.; Glaser, N. Feasibility and Impact of Remote Glucose Monitoring Among Patients With Newly Diagnosed Type 1 Diabetes: Single-Center Pilot Study. JMIR Diabetes 2022, 7, e33639. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_VkMWXBV">Diabetes App-Related Text Messages From Health Care Professionals in Conjunction With a New Wireless Glucose Meter With a Color Range Indicator Improves Glycemic Control in Patients With Type 1 and Type 2 Diabetes: Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Grady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cameron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Levy</surname></persName>
		</author>
		<idno type="DOI">10.2196/diabetes.7454</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FKrePY9">JMIR Diabetes</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grady, M.; Katz, L.B.; Cameron, H.; Levy, B.L. Diabetes App-Related Text Messages From Health Care Professionals in Conjunction With a New Wireless Glucose Meter With a Color Range Indicator Improves Glycemic Control in Patients With Type 1 and Type 2 Diabetes: Randomized Controlled Trial. JMIR Diabetes 2017, 2, e19. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_TBRUVbJ">Mobile phone applications and self-management of diabetes: A systematic review with meta-analysis, meta-regression of 21 randomized trials and GRADE</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Diao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Carter</surname></persName>
		</author>
		<idno type="DOI">10.1111/dom.13307</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jREk3j9">Diabetes Obes. Metab</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="2009" to="2013" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hou, C.; Xu, Q.; Diao, S.; Hewitt, J.; Li, J.; Carter, B. Mobile phone applications and self-management of diabetes: A systematic review with meta-analysis, meta-regression of 21 randomized trials and GRADE. Diabetes Obes. Metab. 2018, 20, 2009-2013. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_vXVatgH">Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults with Type 2 Diabetes: A Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Ong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Johal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">V</forename><surname>Yap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Chooi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Chandra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Thiagarajah</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2021.12417</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nD9neKM">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2112417</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lim, S.L.; Ong, K.W.; Johal, J.; Han, C.Y.; Yap, Q.V.; Chan, Y.H.; Chooi, Y.C.; Zhang, Z.P.; Chandra, C.C.; Thiagarajah, A.G.; et al. Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults with Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open 2021, 4, e2112417. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_hXTer4X">Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients with Type 2 Diabetes: 6-Month Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Cha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Yun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">B</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Hyun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Ko</surname></persName>
		</author>
		<idno type="DOI">10.2196/37430</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5yvXjhj">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">37430</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee, E.Y.; Cha, S.A.; Yun, J.S.; Lim, S.Y.; Lee, J.H.; Ahn, Y.B.; Yoon, K.H.; Hyun, M.K.; Ko, S.H. Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients with Type 2 Diabetes: 6-Month Randomized Controlled Trial. J. Med. Internet Res. 2022, 24, e37430. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_VvSbgCU">Effectivness of specific mobile health applications (mHealth-apps) in gestational diabtetes mellitus: A systematic review</title>
		<author>
			<persName><forename type="first">C</forename><surname>Eberle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Loehnert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stichling</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12884-021-04274-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wKfZDyk">BMC Pregnancy Childbirth</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">808</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Eberle, C.; Loehnert, M.; Stichling, S. Effectivness of specific mobile health applications (mHealth-apps) in gestational diabtetes mellitus: A systematic review. BMC Pregnancy Childbirth 2021, 21, 808. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_mAnkdwK">Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Francisa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mayor</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc16-0346</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nTkNhkC">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="2089" to="2095" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hou, C.; Carter, B.; Hewitt, J.; Francisa, T.; Mayor, S. Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials. Diabetes Care 2016, 39, 2089-2095. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_hjGM2nv">Effects of mobile apps intervention on medication adherence and type 2 diabetes mellitus control: A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Bakry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hatah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Mohd Tahir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mustafa</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x231174933</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WH54eKv">J. Telemed. Telecare</title>
		<imprint>
			<biblScope unit="page" from="1357633X" to="231174933" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chong, C.J.; Bakry, M.M.; Hatah, E.; Mohd Tahir, N.A.; Mustafa, N. Effects of mobile apps intervention on medication adherence and type 2 diabetes mellitus control: A systematic review and meta-analysis. J. Telemed. Telecare 2023, 1357633X231174933. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_zR2e4ym">Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Holl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Heinemann</surname></persName>
		</author>
		<idno type="DOI">10.2337/dci19-0062</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ggKprPY">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="250" to="260" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fleming, G.A.; Petrie, J.R.; Bergenstal, R.M.; Holl, R.W.; Peters, A.L.; Heinemann, L. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetes Care 2020, 43, 250-260. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_gZynERV">Web-based telemedicine for management of type 2 diabetes through glucose uploads: A randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RxryywX">Int. J. Clin. Exp. Pathol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="8848" to="8854" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhou, P.; Xu, L.; Liu, X.; Huang, J.; Xu, W.; Chen, W. Web-based telemedicine for management of type 2 diabetes through glucose uploads: A randomized controlled trial. Int. J. Clin. Exp. Pathol. 2014, 7, 8848-8854.</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_vzZFQNu">The impact of electronic education on metabolic control indicators in patients with diabetes who need insulin: A randomised clinical control trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Moattari</surname></persName>
		</author>
		<author>
			<persName><surname>Hashemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Dabbaghmanesh</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2702.2012.04200.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AmZHQSr">J. Clin. Nurs</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="32" to="38" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moattari, M.; Hashemi, Dabbaghmanesh, M.H. The impact of electronic education on metabolic control indicators in patients with diabetes who need insulin: A randomised clinical control trial. J. Clin. Nurs. 2013, 22, 32-38. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main" xml:id="_gf2SDdb">Successful Delivery of Diabetes Self-Care Education and Follow-Up through eHealth Media</title>
		<author>
			<persName><forename type="first">D</forename><surname>Pacaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kelley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Downey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chiasson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jcjd.2012.08.006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FF7E4EK">Can. J. Diab</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="257" to="262" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pacaud, D.; Kelley, H.; Downey, A.M.; Chiasson, M. Successful Delivery of Diabetes Self-Care Education and Follow-Up through eHealth Media. Can. J. Diab. 2012, 36, 257-262. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main" xml:id="_ACP9hu3">Effectiveness of telemonitoring intervention on glycaemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sawhney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Broadley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sun</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2023.110727</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kQqAChS">Diabetes Res. Clin. Pract</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page">110727</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cai, J.; Xu, H.; Jiang, S.; Sung, J.; Sawhney, R.; Broadley, S.; Sun, J. Effectiveness of telemonitoring intervention on glycaemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res. Clin. Pract. 2023, 201, 110727. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main" xml:id="_5GJH97q">A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nicolucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cercone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiriatti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Muscas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gensini</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2014.0355</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_X2Q2F5P">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="563" to="570" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nicolucci, A.; Cercone, S.; Chiriatti, A.; Muscas, F.; Gensini, G. A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes. Diabetes Technol. Ther. 2015, 17, 563-570. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main" xml:id="_WhfA6qJ">DIABEO System Combining a Mobile App Software with and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen</title>
		<author>
			<persName><forename type="first">S</forename><surname>Franc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hanaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Benhamou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schaepelynck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Catargi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fontaine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Guerci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Reznik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jeandidier</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2020.0021</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7HbYQ9B">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="904" to="911" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Franc, S.; Hanaire, H.; Benhamou, P.Y.; Schaepelynck, P.; Catargi, B.; Farret, A.; Fontaine, P.; Guerci, B.; Reznik, Y.; Jeandi- dier, N.; et al. DIABEO System Combining a Mobile App Software with and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen. Diabetes Technol. Ther. 2020, 22, 904-911. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main" xml:id="_7Hy7muM">Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Wild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mcknight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Mccloughan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Padfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pinnock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sheikh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QCmg3jD">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">1002098</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wild, S.H.; Hanley, J.; Lewis, S.C.; McKnight, J.A.; McCloughan, L.B.; Padfield, P.L.; Parker, R.A.; Paterson, M.; Pinnock, H.; Sheikh, A.; et al. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial. PLoS Med. 2016, 13, e1002098.</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main" xml:id="_zXpknZp">Experimentation of 2.0 telemedicine in elderly patients with chronic heart failure: A study prospective in 175 patients</title>
		<author>
			<persName><forename type="first">E</forename><surname>AndrÃ¨s</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Talha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hajjam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hajjam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>ErvÃ©</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hajjam</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejim.2018.02.022</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WVEAFQu">Eur. J. Intern. Med</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="11" to="e12" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">AndrÃ¨s, E.; Talha, S.; Hajjam, M.; Hajjam, J.; ErvÃ©, S.; Hajjam, A. Experimentation of 2.0 telemedicine in elderly patients with chronic heart failure: A study prospective in 175 patients. Eur. J. Intern. Med. 2018, 51, e11-e12. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main" xml:id="_Qsg87qF">Association between diabetes control and visits to a multidisciplinary pediatric diabetes clinic</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Halvorson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
		<idno type="DOI">10.1542/peds.103.5.948</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WXxp5ag">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="948" to="951" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kaufman, F.R.; Halvorson, M.; Carpenter, S. Association between diabetes control and visits to a multidisciplinary pediatric diabetes clinic. Pediatrics 1999, 103, 948-951. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main" xml:id="_KHxw27R">Use of Telemedicine for Management of Diabetes in Correctional Facilities</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kassar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Roe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Desimone</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2016.0036</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UBrJQ5u">Telemed. J. E Health</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="55" to="59" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kassar, K.; Roe, C.; Desimone, M. Use of Telemedicine for Management of Diabetes in Correctional Facilities. Telemed. J. E Health 2017, 23, 55-59. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main" xml:id="_xFajgPB">Televisits to Partially Substitute for Clinic Visits Are Feasible and Well Accepted by Tech-Savvy Patients With T1DM and Their Families: A Prospective Pilot Study</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Tonyushkina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cobb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moskovitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Allen</surname></persName>
		</author>
		<idno type="DOI">10.1177/1932296818775438</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qHxgpZn">J. Diabetes Sci. Technol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1084" to="1085" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tonyushkina, K.N.; Cobb, V.; Moskovitz, A.; Allen, H.F. Televisits to Partially Substitute for Clinic Visits Are Feasible and Well Accepted by Tech-Savvy Patients With T1DM and Their Families: A Prospective Pilot Study. J. Diabetes Sci. Technol. 2018, 12, 1084-1085. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main" xml:id="_phQ2j59">Diabetes Education and Support Tele-Visit Needs Differ in Duration, Content, and Satisfaction in Older Versus Younger Adults</title>
		<author>
			<persName><forename type="first">M</forename><surname>Greenfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stegman-Barber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kemmis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Feuerstein-Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Saha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mcarthur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Morley</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmr.2022.0007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_G9skbdj">Telemed. Rep</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="107" to="116" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Greenfield, M.; Stuber, D.; Stegman-Barber, D.; Kemmis, K.; Matthews, B.; Feuerstein-Simon, C.B.; Saha, P.; Wells, B.; McArthur, T.; Morley, C.P.; et al. Diabetes Education and Support Tele-Visit Needs Differ in Duration, Content, and Satisfaction in Older Versus Younger Adults. Telemed. Rep. 2022, 3, 107-116. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main" xml:id="_ZUNb7qq">First televisits provided by the public health system for patients affected by diabetes mellitus in COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">B</forename><surname>Pintaudi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Garavaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">E</forename><surname>Disoteo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meneghini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Epis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bertuzzi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2021.108697</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nCnpcfA">Diabetes Res. Clin. Pract</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page">108697</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note>CrossRef</note>
	<note type="raw_reference">Pintaudi, B.; Garavaglia, G.; Disoteo, O.E.; Meneghini, E.; Epis, O.M.; Colombo, F.; Bertuzzi, F. First televisits provided by the public health system for patients affected by diabetes mellitus in COVID-19 pandemic. Diabetes Res. Clin. Pract. 2021, 173, 108697. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main" xml:id="_fRFFuMM">Use and Perception of Telemedicine in People with Type 1 Diabetes During the COVID-19 Pandemic: A 1-Year Follow-Up</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Fontana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Helleputte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pickles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zueger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stettler</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2021.0426</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_p4t5Cpc">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="276" to="280" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Scott, S.N.; Fontana, F.Y.; Helleputte, S.; Pickles, J.; Laimer, M.; Zueger, T.; Stettler, C. Use and Perception of Telemedicine in People with Type 1 Diabetes During the COVID-19 Pandemic: A 1-Year Follow-Up. Diabetes Technol Ther. 2022, 24, 276-280. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main" xml:id="_d2ZuBNX">Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus</title>
		<author>
			<persName><forename type="first">K</forename><surname>Iglay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hannachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Joseph Howie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rajpathak</surname></persName>
		</author>
		<idno type="DOI">10.1185/03007995.2016.1168291</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vXcaY5R">Curr. Med. Res. Opin</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1243" to="1252" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Iglay, K.; Hannachi, H.; Joseph Howie, P.; Xu, J.; Li, X.; Engel, S.S.; Moore, L.M.; Rajpathak, S. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr. Med. Res. Opin. 2016, 2, 1243-1252. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main" xml:id="_ddD2bCw">Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials</title>
		<author>
			<persName><forename type="first">D</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kelley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Michaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Siahpush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Stimpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>PagÃ¡n</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2016.04.019</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sEggyb3">Diabetes Res. Clin. Pract</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="136" to="148" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Su, D.; Zhou, J.; Kelley, M.S.; Michaud, T.L.; Siahpush, M.; Kim, J.; Wilson, F.; Stimpson, J.P.; PagÃ¡n, J.A. Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res. Clin. Pract. 2016, 116, 136-148. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main" xml:id="_pKVbEXs">Telemedicine assists in the management of proatherogenic dyslipidemia and postprandial glucose variability in patients with type 2 diabetes mellitus: A cross-sectional study</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Kao</surname></persName>
		</author>
		<idno type="DOI">10.1530/EC-21-0209</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WfqmaPV">Endocr. Connect</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="789" to="795" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheng, P.C.; Kao, C.H. Telemedicine assists in the management of proatherogenic dyslipidemia and postprandial glucose variability in patients with type 2 diabetes mellitus: A cross-sectional study. Endocr. Connect. 2021, 10, 789-795. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main" xml:id="_zG84YXd">Efficacy of Telemedicine in Hypertension Care Through Home Blood Pressure Monitoring and Videoconferencing: Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yatabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Yatabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ichihara</surname></persName>
		</author>
		<idno type="DOI">10.2196/27347</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qW9trna">JMIR Cardio</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">27347</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yatabe, J.; Yatabe, M.S.; Okada, R.; Ichihara, A. Efficacy of Telemedicine in Hypertension Care Through Home Blood Pressure Monitoring and Videoconferencing: Randomized Controlled Trial. JMIR Cardio. 2021, 5, e27347. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main" xml:id="_UeFKDx8">Telehealth for patients at high risk of cardiovascular disease: Pragmatic randomised controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><surname>Salisbury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>O'cathain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gaunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hollinghurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicholl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Large</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yardley</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.i2647</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vJkr24k">BMJ</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="page">2647</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Salisbury, C.; O&apos;Cathain, A.; Thomas, C.; Edwards, L.; Gaunt, D.; Dixon, P.; Hollinghurst, S.; Nicholl, J.; Large, S.; Yardley, L.; et al. Telehealth for patients at high risk of cardiovascular disease: Pragmatic randomised controlled trial. BMJ 2016, 353, i2647. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main" xml:id="_jT8ew9g">Meta-analysis of telemonitoring to improve HbA1c levels: Promise for stroke survivors</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Lieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Appelboom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bruce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bruce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Christophe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Connolly</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jocn.2014.11.009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xewsbse">J. Clin. Neurosci</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="807" to="811" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lieber, B.A.; Taylor, B.; Appelboom, G.; Prasad, K.; Bruce, S.; Yang, A.; Bruce, E.; Christophe, B.; Connolly, E.S., Jr. Meta-analysis of telemonitoring to improve HbA1c levels: Promise for stroke survivors. J. Clin. Neurosci. 2015, 22, 807-811. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main" xml:id="_GKQZjSN">A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Froekjaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Bjerregaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lauritsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hangaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Henriksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Halekoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Yderstraede</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc15-0332</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cVRJeJG">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1723" to="1729" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rasmussen, B.S.; Froekjaer, J.; Bjerregaard, M.R.; Lauritsen, J.; Hangaard, J.; Henriksen, C.W.; Halekoh, U.; Yderstraede, K.B. A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers. Diabetes Care 2015, 38, 1723-1729. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main" xml:id="_tdzpPXh">The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial</title>
		<author>
			<persName><forename type="first">H</forename><surname>Smith-StrÃ¸m</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Igland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ãstbye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Tell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Hausken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Graue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Skeie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Iversen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WzRZeC5">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="96" to="103" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smith-StrÃ¸m, H.; Igland, J.; Ãstbye, T.; Tell, G.S.; Hausken, M.F.; Graue, M.; Skeie, S.; Cooper, J.G.; Iversen, M.M. The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial. Diabetes Care 2018, 41, 96-103.</note>
</biblStruct>

<biblStruct xml:id="b88">
	<monogr>
		<title/>
		<idno type="DOI">10.2337/dc17-1025</idno>
		<imprint/>
	</monogr>
	<note type="raw_reference">CrossRef</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main" xml:id="_YtpnU8T">Effect of a telemedicine intervention for diabetes-related foot ulcers on health, well-being and quality of life: Secondary outcomes from a cluster randomized controlled trial (DiaFOTo)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Iversen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Igland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Smith-StrÃ¸m</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ãstbye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Tell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Skeie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peyrot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Graue</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12902-020-00637-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MfnhEXb">BMC Endocr. Disord</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">157</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Iversen, M.M.; Igland, J.; Smith-StrÃ¸m, H.; Ãstbye, T.; Tell, G.S.; Skeie, S.; Cooper, J.G.; Peyrot, M.; Graue, M. Effect of a telemedicine intervention for diabetes-related foot ulcers on health, well-being and quality of life: Secondary outcomes from a cluster randomized controlled trial (DiaFOTo). BMC Endocr. Disord. 2020, 20, 157. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main" xml:id="_uDzrUZJ">The use of telemedicine in the management of diabetes-related foot ulceration: A pilot study</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Wilbright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Birke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Patout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Varnado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Horswell</surname></persName>
		</author>
		<idno type="DOI">10.1097/00129334-200406000-00012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CnrNjNn">Adv. Skin Wound Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="232" to="238" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wilbright, W.A.; Birke, J.A.; Patout, C.A.; Varnado, M.; Horswell, R. The use of telemedicine in the management of diabetes-related foot ulceration: A pilot study. Adv. Skin Wound Care 2004, 17, 232-238. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main" xml:id="_5Yhz4Tz">Patient attitudes toward a Web-based system for monitoring chronic wounds</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lowery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Hamill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Wilkins</surname></persName>
		</author>
		<idno type="DOI">10.1089/1530562042632074</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5XAZDXz">Telemed. J. E Health</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="26" to="34" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>Suppl. S2</note>
	<note type="raw_reference">Kim, H.M.; Lowery, J.C.; Hamill, J.B.; Wilkins, E.G. Patient attitudes toward a Web-based system for monitoring chronic wounds. Telemed. J. E Health 2004, 10 (Suppl. S2), S-26-34. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main" xml:id="_q5nR4EN">An assessment of the accuracy and usability of a novel optical wound measurement system</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Bowling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fadavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Preece</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Daniel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Boulton</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1464-5491.2008.02611.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vj8N2sf">Diabet. Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="93" to="96" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bowling, F.L.; King, L.; Fadavi, H.; Paterson, J.A.; Preece, K.; Daniel, R.W.; Matthews, D.J.; Boulton, A.J. An assessment of the accuracy and usability of a novel optical wound measurement system. Diabet. Med. 2009, 26, 93-96. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main" xml:id="_J2yGaH7">Area of the diabetic ulcers estimated applying a foot scanner-based home telecare system and three reference methods</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ladyzynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Foltynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Molik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tarwacka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Migalska-Musial</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mlynarczuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Wojcicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Krzymien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Karnafel</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2011.0082</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k3zagyn">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1101" to="1107" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ladyzynski, P.; Foltynski, P.; Molik, M.; Tarwacka, J.; Migalska-Musial, K.; Mlynarczuk, M.; Wojcicki, J.M.; Krzymien, J.; Karnafel, W. Area of the diabetic ulcers estimated applying a foot scanner-based home telecare system and three reference methods. Diabetes Technol. Ther. 2011, 13, 1101-1107. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main" xml:id="_Js3n8ZU">Remote assessment of diabetic foot ulcers using a novel wound imaging system</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Bowling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Lipsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Boulton</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1524-475X.2010.00645.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gv7vjhY">Wound Repair. Regen</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="25" to="30" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bowling, F.L.; King, L.; Paterson, J.A.; Hu, J.; Lipsky, B.A.; Matthews, D.R.; Boulton, A.J. Remote assessment of diabetic foot ulcers using a novel wound imaging system. Wound Repair. Regen. 2011, 19, 25-30. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main" xml:id="_PBavQpD">Digital imaging: An accurate and easy method of measuring foot ulcers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Rajbhandari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sutton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lockett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Eaton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gadour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tesfaye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ward</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1464-5491.1999.00053.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3Y2AHPF">Diabet. Med</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="339" to="342" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rajbhandari, S.M.; Harris, N.D.; Sutton, M.; Lockett, C.; Eaton, S.; Gadour, M.; Tesfaye, S.; Ward, J.D. Digital imaging: An accurate and easy method of measuring foot ulcers. Diabet. Med. 1999, 16, 339-342. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main" xml:id="_EZfpAVB">Assessment of signs of foot infection in diabetes patients using photographic foot imaging and infrared thermography</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Hazenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Van Netten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Van Baal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Bus</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2013.0251</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_d7g6APU">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="370" to="377" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hazenberg, C.E.; van Netten, J.J.; van Baal, S.G.; Bus, S.A. Assessment of signs of foot infection in diabetes patients using photographic foot imaging and infrared thermography. Diabetes Technol. Ther. 2014, 16, 370-377. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main" xml:id="_nthjPT5">Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Holtz-Neiderer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wendel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Kimbriel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Lavery</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjmed.2007.06.028</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zVug6mx">Am. J. Med</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="1042" to="1046" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Armstrong, D.G.; Holtz-Neiderer, K.; Wendel, C.; Mohler, M.J.; Kimbriel, H.R.; Lavery, L.A. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am. J. Med. 2007, 120, 1042-1046. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main" xml:id="_PwBAfxJ">Home monitoring of foot skin temperatures to prevent ulceration</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Lavery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Lanctot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Constantinides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Zamorano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Athanasiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Agrawal</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.27.11.2642</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ygwEXDS">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="2642" to="2647" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lavery, L.A.; Higgins, K.R.; Lanctot, D.R.; Constantinides, G.P.; Zamorano, R.G.; Armstrong, D.G.; Athanasiou, K.A.; Agrawal, C.M. Home monitoring of foot skin temperatures to prevent ulceration. Diabetes Care 2004, 27, 2642-2647. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main" xml:id="_4GwwHuU">Preventing diabetic foot ulcer recurrence in high-risk patients: Use of temperature monitoring as a self-assessment tool</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Lavery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Lanctot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Constantinides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Zamorano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Athanasiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Agrawal</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc06-1600</idno>
		<idno>100</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cXjRMup">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="14" to="20" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lavery, L.A.; Higgins, K.R.; Lanctot, D.R.; Constantinides, G.P.; Zamorano, R.G.; Athanasiou, K.A.; Armstrong, D.G.; Agrawal, C.M. Preventing diabetic foot ulcer recurrence in high-risk patients: Use of temperature monitoring as a self-assessment tool. Diabetes Care 2007, 30, 14-20. [CrossRef] 100</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main" xml:id="_TUsbmjW">A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes--a randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Skafjeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Iversen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Holme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ribu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hvaal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Kilhovd</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12902-015-0054-x</idno>
		<idno>101</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uwyt69v">BMC Endocr. Disord</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">55</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Skafjeld, A.; Iversen, M.M.; Holme, I.; Ribu, L.; Hvaal, K.; Kilhovd, B.K. A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes--a randomized controlled trial. BMC Endocr. Disord. 2015, 15, 55. [CrossRef] 101</note>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main" xml:id="_knQeZsr">Use of liquid crystal thermography in the evaluation of the diabetic foot</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Stess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Sisney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Graf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Louie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Gooding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Grunfeld</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.9.3.267</idno>
		<idno>102</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5Uqngc3">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="267" to="272" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stess, R.M.; Sisney, P.C.; Moss, K.M.; Graf, P.M.; Louie, K.S.; Gooding, G.A.; Grunfeld, C. Use of liquid crystal thermography in the evaluation of the diabetic foot. Diabetes Care 1986, 9, 267-272. [CrossRef] 102</note>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main" xml:id="_kZPCQqQ">The prediction of diabetic neuropathic plantar foot ulceration by liquid-crystal contact thermography</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Benbow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Bowsher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Macfarlane</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.17.8.835</idno>
		<idno>103</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DgVRqzJ">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="835" to="839" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Benbow, S.J.; Chan, A.W.; Bowsher, D.R.; Williams, G.; Macfarlane, I.A. The prediction of diabetic neuropathic plantar foot ulceration by liquid-crystal contact thermography. Diabetes Care 1994, 17, 835-839. [CrossRef] 103</note>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main" xml:id="_AxVrb3J">Feasibility of a thermographic method for early detection of foot disorders in diabetes</title>
		<author>
			<persName><forename type="first">K</forename><surname>Roback</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Starkhammar</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2009.0053</idno>
		<idno>104</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hH2Nepz">Diabetes Technol. Ther</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="663" to="667" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roback, K.; Johansson, M.; Starkhammar, A. Feasibility of a thermographic method for early detection of foot disorders in diabetes. Diabetes Technol. Ther. 2009, 11, 663-667. [CrossRef] 104</note>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main" xml:id="_UA4q5sJ">Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Frykberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Reyzelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Cazzell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Rothenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Bloom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Linders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nouvong</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc16-2294</idno>
		<idno>105</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TNxfGWd">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="973" to="980" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Frykberg, R.G.; Gordon, I.L.; Reyzelman, A.M.; Cazzell, S.M.; Fitzgerald, R.H.; Rothenberg, G.M.; Bloom, J.D.; Petersen, B.J.; Linders, D.R.; Nouvong, A.; et al. Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers. Diabetes Care 2017, 40, 973-980. [CrossRef] [PubMed] 105</note>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main" xml:id="_JkT7d5a">Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Rajbhandari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tesfaye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ward</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.22.8.1292</idno>
		<idno>106</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HkTcqVc">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1292" to="1295" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rajbhandari, S.M.; Harris, N.D.; Tesfaye, S.; Ward, J.D. Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care 1999, 22, 1292-1295. [CrossRef] [PubMed] 106</note>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main" xml:id="_AMYmJfF">Noninvasive assessment of diabetic foot ulcers with diffuse photon density wave methodology: Pilot human study</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Papazoglou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Neidrauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zubkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Weingarten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pourrezaei</surname></persName>
		</author>
		<idno type="DOI">10.1117/1.3275467</idno>
		<idno>107</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TJUWPrK">J. Biomed. Opt</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">64032</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Papazoglou, E.S.; Neidrauer, M.; Zubkov, L.; Weingarten, M.S.; Pourrezaei, K. Noninvasive assessment of diabetic foot ulcers with diffuse photon density wave methodology: Pilot human study. J. Biomed. Opt. 2009, 14, 064032. [CrossRef] 107</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main" xml:id="_5Mex95Z">Near infrared wound monitor helps clinical assessment of diabetic foot ulcers</title>
		<author>
			<persName><forename type="first">M</forename><surname>Neidrauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zubkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Weingarten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pourrezaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Papazoglou</surname></persName>
		</author>
		<idno type="DOI">10.1177/193229681000400404</idno>
		<idno>108</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_THpw7pp">J. Diabetes Sci. Technol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="792" to="798" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Neidrauer, M.; Zubkov, L.; Weingarten, M.S.; Pourrezaei, K.; Papazoglou, E.S. Near infrared wound monitor helps clinical assessment of diabetic foot ulcers. J. Diabetes Sci. Technol. 2010, 4, 792-798. [CrossRef] 108</note>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main" xml:id="_BdM8G68">Prediction of wound healing in human diabetic foot ulcers by diffuse near-infrared spectroscopy: A pilot study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Weingarten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Neidrauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mateo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Mao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Mcdaniel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bouraee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zubkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pourrezaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Papazoglou</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1524-475x.2010.00583.x</idno>
		<idno>109</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cAKP3Yv">Wound Repair. Regen</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="180" to="185" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weingarten, M.S.; Neidrauer, M.; Mateo, A.; Mao, X.; McDaniel, J.E.; Jenkins, L.; Bouraee, S.; Zubkov, L.; Pourrezaei, K.; Papazoglou, E.S. Prediction of wound healing in human diabetic foot ulcers by diffuse near-infrared spectroscopy: A pilot study. Wound Repair. Regen. 2010, 18, 180-185. [CrossRef] 109</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main" xml:id="_qFP5zSE">Diffuse near-infrared spectroscopy prediction of healing in diabetic foot ulcers: A human study and cost analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Weingarten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Samuels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Neidrauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Mao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcdaniel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zubkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Papazoglou</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1524-475x.2012.00843.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v6y6RJZ">Wound Repair. Regen</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">110</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weingarten, M.S.; Samuels, J.A.; Neidrauer, M.; Mao, X.; Diaz, D.; McGuire, J.; McDaniel, J.; Jenkins, L.; Zubkov, L.; Papazoglou, E.S. Diffuse near-infrared spectroscopy prediction of healing in diabetic foot ulcers: A human study and cost analysis. Wound Repair. Regen. 2012, 20, 911-917. [CrossRef] 110</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main" xml:id="_kpDGxBm">Evaluation of diabetic foot ulcer healing with hyperspectral imaging of oxyhemoglobin and deoxyhemoglobin</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nouvong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hoogwerf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tajaddini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Medenilla</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc08-2246</idno>
		<idno>111</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pZcqF8M">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="2056" to="2061" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nouvong, A.; Hoogwerf, B.; Mohler, E.; Davis, B.; Tajaddini, A.; Medenilla, E. Evaluation of diabetic foot ulcer healing with hyperspectral imaging of oxyhemoglobin and deoxyhemoglobin. Diabetes Care 2009, 32, 2056-2061. [CrossRef] 111</note>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main" xml:id="_PmAWuKC">The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Khaodhiar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dinh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Schomacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Panasyuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Panasyuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Giurini</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc06-2209</idno>
		<idno>112</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k6BqQF4">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="903" to="910" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Khaodhiar, L.; Dinh, T.; Schomacker, K.T.; Panasyuk, S.V.; Freeman, J.E.; Lew, R.; Vo, T.; Panasyuk, A.A.; Lima, C.; Giurini, J.M.; et al. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care 2007, 30, 903-910. [CrossRef] [PubMed] 112</note>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main" xml:id="_nydZZub">Coping and resilience in adolescents with type 1 diabetes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Jaser</surname></persName>
		</author>
		<author>
			<persName><surname>White</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2214.2010.01184.x</idno>
		<idno>113</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qU2awfB">Child Care Health Dev</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="335" to="342" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jaser, S.S.; White, Coping and resilience in adolescents with type 1 diabetes. Child Care Health Dev. 2011, 37, 335-342. [CrossRef] 113</note>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main" xml:id="_G43qmk4">Implementation of Depression Screening and Global Health Assessment in Pediatric Subspecialty Clinics</title>
		<author>
			<persName><forename type="first">E</forename><surname>Iturralde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Barley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Christofferson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Hanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Maahs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Milla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Naranjo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Shah</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jadohealth.2017.05.030</idno>
		<idno>114</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zq5pezY">J. Adolesc. Health</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="591" to="598" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Iturralde, E.; Adams, R.N.; Barley, R.C.; Bensen, R.; Christofferson, M.; Hanes, S.J.; Maahs, D.M.; Milla, C.; Naranjo, D.; Shah, A.C.; et al. Implementation of Depression Screening and Global Health Assessment in Pediatric Subspecialty Clinics. J. Adolesc. Health 2017, 61, 591-598. [CrossRef] 114</note>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main" xml:id="_sy5xxTX">Digital Interventions for Psychological Comorbidities in Chronic Diseases-A Systematic Review</title>
		<author>
			<persName><forename type="first">M</forename><surname>Maisto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Diana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Di Tella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Matamala-Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Montana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rossetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Mavrodiev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cavalera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Blasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mantovani</surname></persName>
		</author>
		<idno type="DOI">10.3390/jpm11010030</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QrWDZgC">J. Pers. Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">30</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note>PubMedDisclaimer/Publisher&apos;s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content</note>
	<note type="raw_reference">Maisto, M.; Diana, B.; Di Tella, S.; Matamala-Gomez, M.; Montana, J.I.; Rossetto, F.; Mavrodiev, P.A.; Cavalera, C.; Blasi, V.; Mantovani, F.; et al. Digital Interventions for Psychological Comorbidities in Chronic Diseases-A Systematic Review. J. Pers. Med. 2021, 11, 30. [CrossRef] PubMedDisclaimer/Publisher&apos;s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
